This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Burns and corrosions of multiple and unspecified body regions
ST19_BURNS_CORROSIO_MULTIPLE_UNSPE_BODY_REGIONS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
921 |
4. Check minimum number of eventsNone |
921 |
5. Include endpointsNone |
921 |
6. Filter based on genotype QC (FinnGen only) |
890 |
Control definitions (FinnGen only)
- Control exclude
- ST19_BURNS_CORROSIO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T2|T3[0-2]
- Name in latin
- Combustiones et corrosiones regionum corporis multarum sive non specificatarum
Similar endpoints
↥List of similar endpoints to
Burns and corrosions of multiple and unspecified body regions
based on the number of shared cases.
Similar with more cases:
- Burns and corrosions
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 890 | 358 | 532 |
| Unadjusted period prevalence (%) | 0.20 | 0.13 | 0.24 |
| Median age at first event (years) | 49.71 | 45.74 | 52.38 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 921
- Matched controls
- 9210
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S14
ICPC
Burn/scald
23.1
301.8
237
136
T31.0
ICD-10 Finland
Burns involving less than 10% of body surface
+∞
250.8
229
*
ZZA00
NOMESCO Finland
Split skin graft
24.5
246.1
184
93
X12
ICD-10 Finland
Contact with other hot fluids
703.5
229.1
217
*
T29.2
ICD-10 Finland
Burns of multiple regions, no more than second-degree burns mentioned
+∞
216.4
199
*
T30.0
ICD-10 Finland
Burn of unspecified body region, unspecified degree
281.6
143.6
143
6
T23.2
ICD-10 Finland
Burn of second degree of wrist and hand
51.4
138.1
80
17
QBD20
NOMESCO Finland
Excision of burn of trunk and coverage
+∞
132.6
124
*
QCD20
NOMESCO Finland
Excision of burn of upper limb and coverage
+∞
128.2
120
*
QDD00
NOMESCO Finland
Dressing of major burn of lower limb
+∞
127.1
119
*
T21.2
ICD-10 Finland
Burn of second degree of trunk
272.8
118.9
119
5
QDD20
NOMESCO Finland
Excision of burn of lower limb and coverage
+∞
117.2
110
*
QBD00
NOMESCO Finland
Dressing of major burn of trunk
1233.2
114.1
109
*
T31.1
ICD-10 Finland
Burns involving 10-19% of body surface
+∞
114.0
107
*
QCD00
NOMESCO Finland
Dressing of major burn of upper limb
1207.5
112.0
107
*
X18
ICD-10 Finland
Contact with other hot metals
+∞
111.8
105
*
T29.3
ICD-10 Finland
Burns of multiple regions, at least one burn of third degree mentioned
+∞
97.7
92
*
R4120
NOMESCO Finland
Occupational therapy
6.8
96.6
170
297
T22.2
ICD-10 Finland
Burn of second degree of shoulder and upper limb, except wrist and hand
115.4
78.4
84
8
X59
ICD-10 Finland
Exposure to unspecified factor
3.8
75.3
326
1171
T29.0
ICD-10 Finland
Burns of multiple regions, unspecified degree
+∞
75.0
71
*
T24.2
ICD-10 Finland
Burn of second degree of hip and lower limb, except ankle and foot
252.2
69.3
70
*
X14
ICD-10 Finland
Contact with hot air and gases
+∞
61.1
58
*
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
10.0
58.7
69
74
T20.2
ICD-10 Finland
Burn of second degree of head and neck
299.1
55.9
56
*
X09
ICD-10 Finland
Exposure to unspecified smoke, fire and flames
198.5
54.6
56
*
TQW10
NOMESCO Finland
Exchange of bandage for burn
191.0
52.5
54
*
T30.2
ICD-10 Finland
Burn of second degree, body region unspecified
536.9
52.0
51
*
T21.3
ICD-10 Finland
Burn of third degree of trunk
+∞
51.5
49
*
X19
ICD-10 Finland
Contact with other and unspecified heat and hot substances
525.7
50.9
50
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.7
49.3
183
577
X04
ICD-10 Finland
Exposure to ignition of highly flammable material
+∞
47.3
45
*
QBD10
NOMESCO Finland
Debridement of burn of trunk
+∞
47.3
45
*
QCD10
NOMESCO Finland
Debridement of burn of upper limb
+∞
46.2
44
*
T29.1
ICD-10 Finland
Burns of multiple regions, no more than first-degree burns mentioned
+∞
46.2
44
*
X00
ICD-10 Finland
Exposure to uncontrolled fire in building or structure
241.8
45.4
46
*
QAD00
NOMESCO Finland
Dressing of major burn of head or neck
+∞
43.1
41
*
T21.0
ICD-10 Finland
Burn of unspecified degree of trunk
219.8
41.2
42
*
W92
ICD-10 Finland
Exposure to excessive heat of man-made origin
150.2
41.1
43
*
X58
ICD-10 Finland
Exposure to other specified factors
2.9
40.4
231
939
QDD10
NOMESCO Finland
Debridement of burn of lower limb
+∞
39.9
38
*
X06
ICD-10 Finland
Exposure to ignition or melting of other clothing and apparel
+∞
38.8
37
*
T24.3
ICD-10 Finland
Burn of third degree of hip and lower limb, except ankle and foot
393.0
38.3
38
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.8
37.1
70
128
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.8
36.9
87
194
T31.2
ICD-10 Finland
Burns involving 20-29% of body surface
+∞
36.7
35
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.3
32.4
68
137
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.6
32.0
80
187
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.5
32.0
119
371
T22.0
ICD-10 Finland
Burn of unspecified degree of shoulder and upper limb, except wrist and hand
117.6
31.9
34
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
7.0
31.7
49
73
T22.3
ICD-10 Finland
Burn of third degree of shoulder and upper limb, except wrist and hand
+∞
30.4
29
*
T20.0
ICD-10 Finland
Burn of unspecified degree of head and neck
+∞
29.3
28
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.4
28.3
74
179
T31.3
ICD-10 Finland
Burns involving 30-39% of body surface
+∞
27.2
26
*
T24.0
ICD-10 Finland
Burn of unspecified degree of hip and lower limb, except ankle and foot
+∞
27.2
26
*
N03AX16
ATC
[U] pregabalin
2.4
27.2
238
1169
X03
ICD-10 Finland
Exposure to controlled fire, not in building or structure
278.8
26.9
27
*
T32.0
ICD-10 Finland
Corrosions involving less than 10% of body surface
+∞
26.2
25
*
T25.3
ICD-10 Finland
Burn of third degree of ankle and foot
+∞
26.2
25
*
X01
ICD-10 Finland
Exposure to uncontrolled fire, not in building or structure
+∞
26.2
25
*
QAD20
NOMESCO Finland
Excision of burn of head or neck and coverage
+∞
26.2
25
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
26.0
345
2007
T30.1
ICD-10 Finland
Burn of first degree, body region unspecified
+∞
25.1
24
*
T95.1
ICD-10 Finland
Sequelae of burn, corrosion and frostbite of trunk
+∞
25.1
24
*
A46
ICD-10 Finland
Erysipelas
2.6
25.0
172
753
T23.3
ICD-10 Finland
Burn of third degree of wrist and hand
256.8
24.8
25
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
22.7
24.5
35
16
T21.1
ICD-10 Finland
Burn of first degree of trunk
57.7
24.1
28
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
23.7
189
885
F10.20
ICD-10 Finland
Alcohol dependence currently independent
5.5
23.5
46
87
R4110
NOMESCO Finland
Physiotherapy
2.1
23.3
285
1593
X76
ICD-10 Finland
Intentional self-harm by smoke, fire and flames
+∞
23.0
22
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
22.9
154
665
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
22.8
132
529
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
26.7
22.8
31
12
AA1AD
NOMESCO Finland
CT of head and brain
2.1
22.3
276
1546
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.5
22.2
163
734
ZXD05
NOMESCO Finland
Urgent procedure
2.1
22.1
310
1818
P15
ICPC
Chronic alcohol abuse
4.1
21.7
62
160
ZZA10
NOMESCO Finland
Split skin allograft
+∞
20.9
20
*
Z3226
NOMESCO Finland
Physiotherapist
2.3
20.6
191
950
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
5.5
20.6
40
75
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
20.5
306
1826
N05AH04
ATC
quetiapine; oral
2.2
20.4
210
1090
N07BB01
ATC
disulfiram; oral
3.5
19.7
71
216
T95.2
ICD-10 Finland
Sequelae of burn, corrosion and frostbite of upper limb
204.2
19.6
20
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.2
19.0
77
252
N05AH03
ATC
olanzapine; systemic
2.9
18.9
94
346
T20.3
ICD-10 Finland
Burn of third degree of head and neck
+∞
18.8
18
*
QC9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in upper extremities, unspecified
71.4
18.8
21
*
Z3231
NOMESCO Finland
Registered nurse
2.0
18.7
275
1625
T23.0
ICD-10 Finland
Burn of unspecified degree of wrist and hand
39.3
18.6
23
6
F10.25
ICD-10 Finland
Alcohol dependence continuous use
5.1
18.4
39
79
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
18.1
167
826
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
17.4
335
2154
T25.2
ICD-10 Finland
Burn of second degree of ankle and foot
42.9
17.3
21
5
N05AX08
ATC
risperidone; systemic
2.6
17.1
104
425
Z2446
NOMESCO Finland
Social worker
2.8
16.8
89
339
ZZA40
NOMESCO Finland
Graft of synthetic skin substitute
173.0
16.5
17
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
16.5
394
2696
F10.24
ICD-10 Finland
Alcohol depence active use
4.8
16.5
37
79
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
5.5
16.5
32
60
T23.1
ICD-10 Finland
Burn of first degree of wrist and hand
30.6
16.2
21
7
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.9
15.9
48
129
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
15.9
249
1492
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
15.9
68
230
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.1
15.7
67
226
N03AX09
ATC
lamotrigine; oral
3.1
15.6
67
227
T20.1
ICD-10 Finland
Burn of first degree of head and neck
162.7
15.5
16
*
ZXE00
NOMESCO Finland
One hour or less
1.8
15.4
349
2340
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.9
15.2
74
269
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
6.4
15.1
25
40
N06AX11
ATC
mirtazapine; oral
1.8
15.0
313
2044
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
5.5
15.0
29
54
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
14.7
79
303
T95.3
ICD-10 Finland
Sequelae of burn, corrosion and frostbite of lower limb
+∞
14.6
14
*
TQW40
NOMESCO Finland
Remowal of suture of skin
2.8
14.6
74
275
S01.0
ICD-10 Finland
Open wound of scalp
2.6
14.6
89
364
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.6
14.5
86
347
GBB00
NOMESCO Finland
Tracheostomy
6.1
14.4
25
42
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.2
14.1
38
94
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
14.1
60
202
N05AA02
ATC
levomepromazine; systemic
3.2
13.9
55
177
Z2221
NOMESCO Finland
Medical doctor
1.8
13.9
249
1547
N05BA01
ATC
diazepam; systemic, rectal
2.2
13.8
126
617
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
13.8
156
830
P29
ICPC
Psychological sympt/compl other
2.4
13.7
100
445
T31.4
ICD-10 Finland
Burns involving 40-49% of body surface
+∞
13.6
13
*
N05AF03
ATC
chlorprothixene; systemic
3.9
13.5
40
106
QAD10
NOMESCO Finland
Debridement of burn of head or neck
142.0
13.5
14
*
T24.1
ICD-10 Finland
Burn of first degree of hip and lower limb, except ankle and foot
142.0
13.5
14
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
13.4
107
496
W19
ICD-10 Finland
Unspecified fall
2.3
13.3
107
497
N05BA04
ATC
oxazepam; oral
1.8
13.1
234
1448
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
5.6
13.1
25
46
X57
ICD-10 Finland
Unspecified privation
4.2
12.9
34
83
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.8
12.7
67
254
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
5.6
12.6
24
44
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.2
12.6
51
167
ZXA10
NOMESCO Finland
Bilateral
2.0
12.4
156
860
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.8
12.3
38
104
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
4.7
12.2
28
61
ZXA00
NOMESCO Finland
Right side
1.8
12.1
219
1358
-, ,
ICD-10 Finland
4.5
12.0
29
66
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.3
11.9
46
146
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.9
11.9
58
211
ZXD35
NOMESCO Finland
Usual procedure
3.5
11.8
40
117
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
11.7
97
456
N03AG01
ATC
valproic acid; systemic, rectal
2.6
11.7
69
278
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
5.3
11.6
23
44
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
11.3
11.6
21
19
Y94.0
ICD-10 Finland
Accident at home
4.5
11.5
28
64
T32.2
ICD-10 Finland
Corrosions involving 20-29% of body surface
+∞
11.5
11
*
T95.0
ICD-10 Finland
Sequelae of burn, corrosion and frostbite of head and neck
+∞
11.5
11
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
11.4
406
3012
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.9
11.3
55
200
S06.0
ICD-10 Finland
Concussion
2.1
11.3
118
608
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.1
11.3
48
162
A28
ICPC
Limited function/disability NOS
2.0
11.2
143
791
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.8
11.2
55
201
WX730
NOMESCO Finland
Conventional respirator
5.6
11.2
21
38
N02BF02
ATC
pregabalin; oral
2.6
11.2
67
272
N02BE01
ATC
paracetamol; systemic, rectal
1.9
11.1
791
6984
WX402
NOMESCO Finland
General anaesthesia
1.8
11.1
207
1293
J01FF01
ATC
clindamycin; systemic
1.7
11.0
239
1556
S18
ICPC
Laceration/cut
1.6
11.0
408
3046
N05CD07
ATC
temazepam; oral
2.2
11.0
97
468
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
11.0
120
629
N03AE01
ATC
clonazepam; systemic
2.7
10.9
58
221
N06AX21
ATC
duloxetine; oral
2.1
10.9
110
560
F60.9
ICD-10 Finland
Personality disorder, unspecified
5.2
10.8
22
43
P16
ICPC
Acute alcohol abuse
4.0
10.8
30
76
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
4.6
10.8
25
55
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.9
10.8
51
183
F05.9
ICD-10 Finland
Delirium, unspecified
4.3
10.6
27
64
B18.2
ICD-10 Finland
Chronic viral hepatitis C
4.7
10.5
24
52
QCE25
NOMESCO Finland
Excision and repair of scar of upper limb caused by burn
111.2
10.4
11
*
QD2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in thigh
111.2
10.4
11
*
T22.1
ICD-10 Finland
Burn of first degree of shoulder and upper limb, except wrist and hand
111.2
10.4
11
*
N06AX16
ATC
venlafaxine; oral
1.9
10.4
136
758
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.4
10.4
26
61
N06AX05
ATC
trazodone; oral
3.7
10.3
32
88
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.3
10.2
84
393
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.0
10.2
29
75
M79.6
ICD-10 Finland
Pain in limb
1.6
10.1
370
2742
WX872
NOMESCO Finland
Intensive care
2.7
10.0
54
208
W17
ICD-10 Finland
Other fall from one level to another
2.7
9.7
51
194
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.5
9.6
59
242
E000006, ,
ATC
2.5
9.6
60
249
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.9
9.6
28
74
J01DB01
ATC
cefalexin; oral
1.7
9.5
744
6533
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.3
9.5
75
345
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.2
9.5
25
61
QAE25
NOMESCO Finland
Excision and repair of scar of head or neck caused by burn
+∞
9.4
9
*
QXD00
NOMESCO Finland
Exchange of dressing for burn, unspecified location
+∞
9.4
9
*
N06AB06
ATC
sertraline; oral
1.9
9.3
119
658
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
9.3
106
564
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
7.4
9.2
21
29
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
5.1
9.1
19
38
N05AA01
ATC
chlorpromazine; systemic, rectal
5.1
9.1
19
38
N03AX11
ATC
topiramate; oral
3.5
9.1
31
91
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
8.4
9.1
19
23
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.7
9.0
47
178
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
7.5
9.0
20
27
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
24.3
8.9
12
5
V03AA01, ,
ATC
4.4
8.9
22
51
P19
ICPC
Drug abuse
6.9
8.9
21
31
SPAT1265
SPAT
Breathalyser
5.0
8.9
19
39
E0000UV, ,
ATC
1.5
8.9
362
2727
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.9
8.8
41
146
L28
ICPC
Limited function/disability (L)
1.8
8.7
142
847
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
8.6
43
159
N05AB03
ATC
perphenazine; systemic, rectal
2.9
8.6
39
137
N05AN01
ATC
lithium; oral
3.2
8.6
33
105
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.4
8.4
29
86
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.9
8.4
107
591
T30
ICD-10 Finland
Burn and corrosion, body region unspecified
+∞
8.3
8
*
T31.6
ICD-10 Finland
Burns involving 60-69% of body surface
+∞
8.3
8
*
T27.3
ICD-10 Finland
Burn of respiratory tract, part unspecified
+∞
8.3
8
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.7
8.3
44
168
S97
ICPC
Chronic ulcer skin
2.3
8.3
61
273
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
8.3
185
1206
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.8
8.2
40
146
N05AX12
ATC
aripiprazole; systemic
2.5
8.2
51
211
SPAT1240
SPAT
Therapeutic discussion
1.9
8.2
102
559
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
8.1
61
275
N03AF01
ATC
carbamazepine; oral, rectal
2.6
8.1
46
182
ZY010
NOMESCO Finland
Hospital outpatient
2.3
8.0
61
277
RS220, ,
NOMESCO Finland
4.5
7.9
19
43
Z91.5
ICD-10 Finland
Personal history of self-harm
13.2
7.9
13
10
R60.0
ICD-10 Finland
Localized oedema
1.9
7.8
98
537
WX203
NOMESCO Finland
Infraclavicular plexus blockade
3.4
7.8
27
80
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.4
7.8
28
85
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.0
7.8
33
111
WX882
NOMESCO Finland
High dependency care
3.0
7.8
34
117
ZY000
NOMESCO Finland
Hospital inpatient
3.9
7.7
22
57
N06AB10
ATC
escitalopram; oral
1.6
7.7
188
1250
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
4.6
7.7
18
40
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
7.6
264
1909
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
7.5
59
271
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.8
7.5
37
136
ZXA05
NOMESCO Finland
Left side
1.6
7.5
186
1241
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.0
7.5
21
54
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.6
7.5
24
68
E66.8
ICD-10 Finland
Other obesity
2.3
7.3
52
229
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
7.3
112
655
T32.1
ICD-10 Finland
Corrosions involving 10-19% of body surface
+∞
7.3
7
*
QB5S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in back
+∞
7.3
7
*
T95.9
ICD-10 Finland
Sequelae of unspecified burn, corrosion and frostbite
+∞
7.3
7
*
QDE25
NOMESCO Finland
Excision and repair of scar of lower limb caused by burn
+∞
7.3
7
*
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
9.5
7.3
14
15
E86
ICD-10 Finland
Volume depletion
3.3
7.3
27
84
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
7.2
89
485
N06AB04
ATC
citalopram; systemic
1.6
7.2
163
1062
N03AX14
ATC
levetiracetam; systemic
3.2
7.2
28
90
IEV99
NOMESCO Finland
Other psychiatric network intervention
8.0
7.1
15
19
P03
ICPC
Feeling depressed
1.8
7.1
103
593
A02BC02
ATC
pantoprazole; systemic
1.5
7.1
553
4673
X84
ICD-10 Finland
Intentional self-harm by unspecified means
10.1
7.0
13
13
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
7.0
399
3172
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.8
7.0
34
124
Z71.8
ICD-10 Finland
Other specified counselling
1.5
7.0
298
2239
QDB00
NOMESCO Finland
Suture of skin of lower limb
7.1
7.0
16
23
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.8
7.0
33
119
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
6.9
111
659
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
6.9
93
523
N06AB03
ATC
fluoxetine; oral
1.8
6.8
103
600
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.3
6.7
25
78
N03AX12
ATC
[U] gabapentin; oral
1.7
6.7
128
797
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
7.2
6.7
15
21
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.0
6.7
77
410
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.4
6.7
43
181
-56
ICPC
Dressing/pressure/compress/tamponade
4.1
6.6
18
45
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
6.0
6.6
17
29
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.1
6.6
65
328
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
4.2
6.6
17
41
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
6.6
467
3856
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
6.9
6.5
15
22
R40.2
ICD-10 Finland
Coma, unspecified
6.9
6.5
15
22
S00.0
ICD-10 Finland
Superficial injury of scalp
3.1
6.5
26
85
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
6.2
6.5
16
26
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
6.4
57
276
T25.0
ICD-10 Finland
Burn of unspecified degree of ankle and foot
70.3
6.4
7
*
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
14.4
6.4
10
7
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
2.7
6.4
32
119
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
6.4
360
2845
WX290, ,
SPAT
2.6
6.3
35
137
WX892
NOMESCO Finland
Monitored bed care
2.0
6.3
68
354
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
6.3
72
383
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.9
6.3
18
47
T30.3
ICD-10 Finland
Burn of third degree, body region unspecified
+∞
6.3
6
*
T95.4
ICD-10 Finland
Sequelae of burn and corrosion classifiable only according to extent of body surface involved
+∞
6.3
6
*
T95.8
ICD-10 Finland
Sequelae of other specified burn, corrosion and frostbite
+∞
6.3
6
*
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
5.1
6.2
18
36
S51.8
ICD-10 Finland
Open wound of other parts of forearm
4.0
6.2
17
43
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.3
6.2
23
72
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
2.6
6.2
35
139
G72.8
ICD-10 Finland
Other specified myopathies
3.3
6.2
22
67
R41.0
ICD-10 Finland
Disorientation, unspecified
2.8
6.2
30
110
T74.1
ICD-10 Finland
Physical abuse
3.0
6.2
26
88
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
3.0
6.2
26
88
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.7
6.1
31
116
D10
ICPC
Vomiting
2.0
6.1
62
316
A06AD11
ATC
lactulose; oral
1.7
6.1
106
643
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.1
167
1138
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
8.7
6.1
12
14
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.6
6.1
19
53
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
4.9e-01
1.7e+00
4.7e+00
1.0e+50
6.2e+00
3.8e+00
2.0e+00
cases:3.61%
controls:2.25%
cases:4.84%
controls:0.95%
cases:6.97%
controls:0.07%
cases:32.62%
controls:0.00%
cases:33.64%
controls:0.10%
cases:27.26%
controls:0.82%
cases:14.27%
controls:2.31%
32
199
855
8658
43
84
846
8799
62
6
827
8877
290
0
599
8883
296
9
584
8857
232
71
619
8593
106
176
637
7435
Emergency Room Visit
ER [9203]
ER [9203]
6.4e-01
8.9e-01
2.5e+00
7.3e+00
2.3e+00
1.1e+00
7.1e-01
cases:47.58%
controls:32.35%
cases:24.07%
controls:11.55%
cases:14.29%
controls:1.31%
cases:50.73%
controls:0.07%
cases:13.52%
controls:1.51%
cases:25.38%
controls:10.48%
cases:45.49%
controls:29.06%
422
2865
465
5992
214
1026
675
7857
127
116
762
8767
451
6
438
8877
119
134
761
8732
216
908
635
7756
338
2212
405
5399
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
1.8e+00
2.5e+00
2.5e+00
—
2.7e+00
2.7e+00
2.4e+00
cases:1.35%
controls:0.23%
cases:1.24%
controls:0.10%
cases:0.67%
controls:0.06%
—
—
cases:0.80%
controls:0.06%
cases:1.29%
controls:0.09%
cases:1.62%
controls:0.14%
12
20
875
8837
11
9
878
8874
6
5
883
8878
—
7
5
873
8861
11
8
840
8656
12
11
731
7600
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
F10.1 [45595844]
1.8e+00
2.2e+00
2.8e+00
1.0e+50
2.9e+00
2.3e+00
1.8e+00
cases:4.62%
controls:0.81%
cases:2.47%
controls:0.29%
cases:1.12%
controls:0.07%
cases:0.90%
controls:0.00%
cases:1.02%
controls:0.06%
cases:3.17%
controls:0.32%
cases:4.17%
controls:0.74%
41
72
846
8785
22
26
867
8857
10
6
879
8877
8
0
881
8883
9
5
871
8861
27
28
824
8636
31
56
712
7555
Emergency Medicine
93 [38004510]
93 [38004510]
4.1e-01
7.7e-01
2.3e+00
6.2e+00
2.1e+00
8.6e-01
4.5e-01
cases:16.12%
controls:11.32%
cases:12.26%
controls:6.08%
cases:8.55%
controls:0.89%
cases:22.27%
controls:0.06%
cases:5.91%
controls:0.80%
cases:13.98%
controls:6.42%
cases:25.98%
controls:18.28%
143
1003
744
7854
109
540
780
8343
76
79
813
8804
198
5
691
8878
52
71
828
8795
119
556
732
8108
193
1391
550
6220
Psychiatry
26 [38004469]
26 [38004469]
1.1e+00
1.0e+00
1.6e+00
2.9e+00
2.0e+00
1.7e+00
1.2e+00
cases:15.33%
controls:5.43%
cases:7.99%
controls:3.08%
cases:4.95%
controls:1.07%
cases:1.35%
controls:0.08%
cases:6.82%
controls:1.02%
cases:13.16%
controls:2.65%
cases:17.50%
controls:5.90%
136
481
751
8376
71
274
818
8609
44
95
845
8788
12
7
877
8876
60
90
820
8776
112
230
739
8434
130
449
613
7162
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
9.4e-01
1.6e+00
—
1.0e+50
4.1e+00
2.7e+00
1.7e+00
cases:4.62%
controls:1.85%
cases:3.15%
controls:0.63%
—
—
cases:10.69%
controls:0.00%
cases:5.23%
controls:0.09%
cases:7.87%
controls:0.58%
cases:10.77%
controls:2.13%
41
164
846
8693
28
56
861
8827
—
95
0
794
8883
46
8
834
8858
67
50
784
8614
80
162
663
7449
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
SPAT1148 [2001700249]
4.9e-01
1.1e+00
2.3e+00
1.0e+50
4.4e+00
2.4e+00
8.7e-01
cases:2.25%
controls:1.40%
cases:1.46%
controls:0.50%
cases:1.46%
controls:0.15%
cases:0.56%
controls:0.00%
cases:8.98%
controls:0.12%
cases:4.70%
controls:0.44%
cases:3.36%
controls:1.43%
20
124
867
8733
13
44
876
8839
13
13
876
8870
5
0
884
8883
79
11
801
8855
40
38
811
8626
25
109
718
7502
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
9.4e-01
1.4e+00
2.7e+00
1.0e+50
2.6e+00
1.8e+00
9.7e-01
cases:3.72%
controls:1.49%
cases:2.14%
controls:0.55%
cases:1.01%
controls:0.07%
cases:0.56%
controls:0.00%
cases:0.91%
controls:0.07%
cases:3.29%
controls:0.54%
cases:4.98%
controls:1.94%
33
132
854
8725
19
49
870
8834
9
6
880
8877
5
0
884
8883
8
6
872
8860
28
47
823
8617
37
148
706
7463
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
3.8e-01
8.7e-01
2.5e+00
—
3.8e+00
2.1e+00
1.1e+00
cases:5.64%
controls:3.93%
cases:3.26%
controls:1.40%
cases:1.80%
controls:0.15%
—
—
cases:7.61%
controls:0.19%
cases:8.58%
controls:1.17%
cases:9.69%
controls:3.39%
50
348
837
8509
29
124
860
8759
16
13
873
8870
—
67
17
813
8849
73
101
778
8563
72
258
671
7353
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
1.2e+00
1.5e+00
—
1.0e+50
3.9e+00
2.4e+00
9.8e-01
cases:1.35%
controls:0.40%
cases:1.35%
controls:0.29%
—
—
cases:1.01%
controls:0.00%
cases:2.61%
controls:0.06%
cases:1.53%
controls:0.14%
cases:2.56%
controls:0.97%
12
35
875
8822
12
26
877
8857
—
9
0
880
8883
23
5
857
8861
13
12
838
8652
19
74
724
7537
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
3.2e-01
6.1e-01
1.7e+00
3.1e+00
2.9e+00
7.6e-01
5.0e-01
cases:34.05%
controls:27.28%
cases:15.64%
controls:9.12%
cases:4.39%
controls:0.82%
cases:1.24%
controls:0.06%
cases:13.98%
controls:0.91%
cases:16.45%
controls:8.40%
cases:37.95%
controls:27.00%
302
2416
585
6441
139
810
750
8073
39
73
850
8810
11
5
878
8878
123
81
757
8785
140
728
711
7936
282
2055
461
5556
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
5.4e-01
9.2e-01
2.2e+00
1.0e+50
3.6e+00
1.2e+00
1.1e+00
cases:8.79%
controls:5.33%
cases:2.92%
controls:1.18%
cases:1.12%
controls:0.12%
cases:5.29%
controls:0.00%
cases:4.89%
controls:0.14%
cases:2.82%
controls:0.89%
cases:9.02%
controls:3.07%
78
472
809
8385
26
105
863
8778
10
11
879
8872
47
0
842
8883
43
12
837
8854
24
77
827
8587
67
234
676
7377
Poisoning by systemic antibiotics
T36 [45756588]
T36 [45756588]
2.2e+00
2.9e+00
—
1.0e+50
—
2.2e+00
2.4e+00
cases:3.16%
controls:0.36%
cases:1.35%
controls:0.08%
—
—
cases:0.90%
controls:0.00%
—
—
cases:1.53%
controls:0.17%
cases:3.10%
controls:0.30%
28
32
859
8825
12
7
877
8876
—
8
0
881
8883
—
13
15
838
8649
23
23
720
7588
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
1.5e+00
1.5e+00
2.1e+00
1.0e+50
3.8e+00
1.7e+00
9.2e-01
cases:2.59%
controls:0.60%
cases:1.80%
controls:0.41%
cases:0.56%
controls:0.07%
cases:1.35%
controls:0.00%
cases:2.50%
controls:0.06%
cases:2.00%
controls:0.36%
cases:4.44%
controls:1.81%
23
53
864
8804
16
36
873
8847
5
6
884
8877
12
0
877
8883
22
5
858
8861
17
31
834
8633
33
138
710
7473
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
2.2e+00
2.7e+00
—
1.0e+50
—
2.1e+00
2.3e+00
cases:2.37%
controls:0.26%
cases:1.12%
controls:0.08%
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.06%
controls:0.13%
cases:2.56%
controls:0.25%
21
23
866
8834
10
7
879
8876
—
11
0
878
8883
—
9
11
842
8653
19
19
724
7592
General Surgery
2 [38004447]
2 [38004447]
4.8e-01
8.5e-01
2.6e+00
—
3.4e+00
1.2e+00
6.6e-01
cases:24.46%
controls:16.74%
cases:11.14%
controls:5.10%
cases:7.20%
controls:0.60%
—
—
cases:14.89%
controls:0.61%
cases:14.57%
controls:5.11%
cases:24.23%
controls:14.20%
217
1483
670
7374
99
453
790
8430
64
53
825
8830
—
131
54
749
8812
124
443
727
8221
180
1081
563
6530
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.2e-01
5.9e-01
1.3e+00
3.5e+00
1.8e+00
8.4e-01
5.7e-01
cases:9.70%
controls:6.56%
cases:6.75%
controls:3.86%
cases:2.14%
controls:0.62%
cases:2.59%
controls:0.08%
cases:4.20%
controls:0.72%
cases:8.70%
controls:3.94%
cases:16.15%
controls:9.85%
86
581
801
8276
60
343
829
8540
19
55
870
8828
23
7
866
8876
37
64
843
8802
74
341
777
8323
120
750
623
6861
Chronic alcohol abuse
P15 [2002000811]
P15 [2002000811]
1.6e+00
2.3e+00
—
—
—
3.0e+00
2.0e+00
cases:1.47%
controls:0.30%
cases:1.35%
controls:0.14%
—
—
—
—
—
—
cases:1.53%
controls:0.08%
cases:2.29%
controls:0.32%
13
27
874
8830
12
12
877
8871
—
—
—
13
7
838
8657
17
24
726
7587
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
6.9e-01
9.8e-01
1.9e+00
1.0e+50
3.3e+00
1.2e+00
7.7e-01
cases:6.76%
controls:3.50%
cases:4.39%
controls:1.69%
cases:1.91%
controls:0.29%
cases:1.80%
controls:0.00%
cases:5.68%
controls:0.23%
cases:5.52%
controls:1.78%
cases:10.63%
controls:5.20%
60
310
827
8547
39
150
850
8733
17
26
872
8857
16
0
873
8883
50
20
830
8846
47
154
804
8510
79
396
664
7215
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
ZXE02 [2001311396]
1.1e+00
6.6e-01
—
1.0e+50
3.1e+00
2.2e+00
2.4e+00
cases:1.58%
controls:0.54%
cases:0.56%
controls:0.29%
—
—
cases:0.79%
controls:0.00%
cases:1.25%
controls:0.06%
cases:1.41%
controls:0.16%
cases:2.02%
controls:0.18%
14
48
873
8809
5
26
884
8857
—
7
0
882
8883
11
5
869
8861
12
14
839
8650
15
14
728
7597
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
4.3e-01
9.5e-01
2.1e+00
1.0e+50
2.8e+00
1.4e+00
1.0e+00
cases:9.02%
controls:6.04%
cases:3.26%
controls:1.28%
cases:1.12%
controls:0.14%
cases:1.46%
controls:0.00%
cases:2.95%
controls:0.19%
cases:4.82%
controls:1.18%
cases:9.15%
controls:3.59%
80
535
807
8322
29
114
860
8769
10
12
879
8871
13
0
876
8883
26
17
854
8849
41
102
810
8562
68
273
675
7338
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
1.2e+00
1.3e+00
—
—
—
4.8e+00
2.6e+00
cases:2.03%
controls:0.62%
cases:0.67%
controls:0.19%
—
—
—
—
—
—
cases:11.52%
controls:0.10%
cases:5.25%
controls:0.41%
18
55
869
8802
6
17
883
8866
—
—
—
98
9
753
8655
39
31
704
7580
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
7.1e-01
1.1e+00
—
—
4.1e+00
2.5e+00
1.2e+00
cases:4.28%
controls:2.16%
cases:1.35%
controls:0.46%
—
—
—
—
cases:4.09%
controls:0.07%
cases:5.05%
controls:0.42%
cases:3.90%
controls:1.24%
38
191
849
8666
12
41
877
8842
—
—
36
6
844
8860
43
36
808
8628
29
94
714
7517
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
4.7e-01
7.3e-01
2.2e+00
—
3.5e+00
1.2e+00
9.4e-01
cases:6.76%
controls:4.32%
cases:4.72%
controls:2.33%
cases:2.36%
controls:0.26%
—
—
cases:8.18%
controls:0.28%
cases:5.88%
controls:1.85%
cases:11.31%
controls:4.76%
60
383
827
8474
42
207
847
8676
21
23
868
8860
—
72
25
808
8841
50
160
801
8504
84
362
659
7249
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
8.6e-01
1.1e+00
1.4e+00
—
1.9e+00
1.9e+00
1.4e+00
cases:7.10%
controls:3.13%
cases:4.39%
controls:1.45%
cases:1.80%
controls:0.45%
—
—
cases:3.18%
controls:0.48%
cases:8.70%
controls:1.44%
cases:10.36%
controls:2.88%
63
277
824
8580
39
129
850
8754
16
40
873
8843
—
28
43
852
8823
74
125
777
8539
77
219
666
7392
Paranoid schizophrenia continuous
F20.00 [2000501920]
F20.00 [2000501920]
1.7e+00
1.5e+00
—
—
2.7e+00
2.4e+00
1.8e+00
cases:1.24%
controls:0.24%
cases:0.79%
controls:0.17%
—
—
—
—
cases:0.80%
controls:0.06%
cases:1.18%
controls:0.10%
cases:1.62%
controls:0.28%
11
21
876
8836
7
15
882
8868
—
—
7
5
873
8861
10
9
841
8655
12
21
731
7590
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
1.9e-01
2.6e-01
1.2e+00
4.3e+00
2.0e+00
6.5e-01
3.0e-01
cases:27.28%
controls:23.71%
cases:19.57%
controls:15.74%
cases:9.45%
controls:2.97%
cases:12.49%
controls:0.20%
cases:19.89%
controls:3.20%
cases:26.79%
controls:16.03%
cases:41.18%
controls:34.08%
242
2100
645
6757
174
1398
715
7485
84
264
805
8619
111
18
778
8865
175
284
705
8582
228
1389
623
7275
306
2594
437
5017
Unspecified nonorganic psychosis
F29 [45533099]
F29 [45533099]
1.1e+00
1.5e+00
2.5e+00
—
—
1.7e+00
1.6e+00
cases:1.69%
controls:0.55%
cases:1.01%
controls:0.23%
cases:0.67%
controls:0.06%
—
—
—
—
cases:0.94%
controls:0.17%
cases:1.62%
controls:0.33%
15
49
872
8808
9
20
880
8863
6
5
883
8878
—
—
8
15
843
8649
12
25
731
7586
General Practice
1 [38004446]
1 [38004446]
8.0e-01
9.6e-01
1.7e+00
—
2.8e+00
1.4e+00
7.6e-01
cases:21.53%
controls:11.02%
cases:11.25%
controls:4.63%
cases:3.49%
controls:0.64%
—
—
cases:9.09%
controls:0.60%
cases:15.63%
controls:4.49%
cases:24.09%
controls:12.94%
191
976
696
7881
100
411
789
8472
31
57
858
8826
—
80
53
800
8813
133
389
718
8275
179
985
564
6626
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
1.1e+00
1.3e+00
—
—
3.4e+00
1.8e+00
7.9e-01
cases:2.71%
controls:0.91%
cases:2.14%
controls:0.57%
—
—
—
—
cases:2.61%
controls:0.09%
cases:2.82%
controls:0.48%
cases:4.31%
controls:2.01%
24
81
863
8776
19
51
870
8832
—
—
23
8
857
8858
24
42
827
8622
32
153
711
7458
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
5.6e-01
9.9e-01
1.9e+00
1.0e+50
2.5e+00
1.4e+00
1.0e+00
cases:9.58%
controls:5.70%
cases:3.49%
controls:1.33%
cases:1.01%
controls:0.16%
cases:2.59%
controls:0.00%
cases:2.50%
controls:0.20%
cases:4.35%
controls:1.10%
cases:8.21%
controls:3.13%
85
505
802
8352
31
118
858
8765
9
14
880
8869
23
0
866
8883
22
18
858
8848
37
95
814
8569
61
238
682
7373
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
3.7e-01
5.3e-01
1.2e+00
3.6e+00
1.7e+00
8.1e-01
4.9e-01
cases:10.37%
controls:7.38%
cases:7.31%
controls:4.44%
cases:2.25%
controls:0.69%
cases:2.47%
controls:0.07%
cases:4.32%
controls:0.85%
cases:9.40%
controls:4.40%
cases:17.36%
controls:11.42%
92
654
795
8203
65
394
824
8489
20
61
869
8822
22
6
867
8877
38
75
842
8791
80
381
771
8283
129
869
614
6742
Inpatient Hospital
21 [8717]
21 [8717]
4.2e-01
8.1e-01
2.3e+00
—
2.9e+00
1.0e+00
6.2e-01
cases:39.91%
controls:30.35%
cases:20.47%
controls:10.26%
cases:10.12%
controls:1.07%
—
—
cases:19.77%
controls:1.34%
cases:21.50%
controls:9.08%
cases:35.67%
controls:22.89%
354
2688
533
6169
182
911
707
7972
90
95
799
8788
—
174
119
706
8747
183
787
668
7877
265
1742
478
5869
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
2.2e-01
1.1e+00
2.6e+00
—
3.4e+00
7.9e-01
9.3e-01
cases:5.30%
controls:4.29%
cases:2.92%
controls:1.04%
cases:1.35%
controls:0.10%
—
—
cases:2.84%
controls:0.10%
cases:1.88%
controls:0.87%
cases:7.54%
controls:3.13%
47
380
840
8477
26
92
863
8791
12
9
877
8874
—
25
9
855
8857
16
75
835
8589
56
238
687
7373
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
2.7e-01
6.0e-01
2.4e+00
1.0e+50
3.7e+00
1.7e+00
4.4e-01
cases:3.72%
controls:2.86%
cases:1.35%
controls:0.74%
cases:0.90%
controls:0.08%
cases:1.57%
controls:0.00%
cases:2.27%
controls:0.06%
cases:2.94%
controls:0.53%
cases:3.36%
controls:2.19%
33
253
854
8604
12
66
877
8817
8
7
881
8876
14
0
875
8883
20
5
860
8861
25
46
826
8618
25
167
718
7444
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
F60.31 [2000502023]
2.6e+00
—
—
—
—
2.5e+00
2.8e+00
cases:1.58%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.08%
cases:1.75%
controls:0.11%
14
11
873
8846
—
—
—
—
8
7
843
8657
13
8
730
7603
Outpatient Hospital
22 [8756]
22 [8756]
3.6e-01
7.4e-01
2.2e+00
—
2.8e+00
9.5e-01
6.5e-01
cases:30.10%
controls:23.02%
cases:13.27%
controls:6.80%
cases:6.07%
controls:0.69%
—
—
cases:11.93%
controls:0.79%
cases:13.98%
controls:5.93%
cases:27.32%
controls:16.41%
267
2039
620
6818
118
604
771
8279
54
61
835
8822
—
105
70
775
8796
119
514
732
8150
203
1249
540
6362
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.4e-01
2.3e-01
1.1e+00
4.2e+00
1.7e+00
5.0e-01
3.1e-01
cases:27.85%
controls:25.18%
cases:23.17%
controls:19.37%
cases:10.12%
controls:3.78%
cases:12.04%
controls:0.21%
cases:19.09%
controls:3.97%
cases:28.67%
controls:19.54%
cases:44.41%
controls:36.97%
247
2230
640
6627
206
1721
683
7162
90
336
799
8547
107
19
782
8864
168
352
712
8514
244
1693
607
6971
330
2814
413
4797
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
2.2e-01
2.7e-01
1.0e+00
4.1e+00
1.8e+00
4.9e-01
3.6e-01
cases:21.65%
controls:18.11%
cases:19.12%
controls:15.25%
cases:8.77%
controls:3.35%
cases:9.34%
controls:0.17%
cases:16.14%
controls:3.23%
cases:23.74%
controls:15.97%
cases:38.09%
controls:30.10%
192
1604
695
7253
170
1355
719
7528
78
298
811
8585
83
15
806
8868
142
286
738
8580
202
1384
649
7280
283
2291
460
5320
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.4e-01
2.4e-01
1.0e+00
4.1e+00
1.7e+00
5.0e-01
3.0e-01
cases:28.07%
controls:25.28%
cases:23.51%
controls:19.51%
cases:10.01%
controls:3.82%
cases:11.92%
controls:0.21%
cases:18.98%
controls:3.99%
cases:28.79%
controls:19.74%
cases:44.41%
controls:37.12%
249
2239
638
6618
209
1733
680
7150
89
339
800
8544
106
19
783
8864
167
354
713
8512
245
1710
606
6954
330
2825
413
4786
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
5.8e-01
7.0e-01
2.2e+00
—
2.7e+00
9.5e-01
4.7e-01
cases:6.43%
controls:3.70%
cases:4.50%
controls:2.29%
cases:3.15%
controls:0.35%
—
—
cases:3.52%
controls:0.25%
cases:5.99%
controls:2.40%
cases:12.65%
controls:8.26%
57
328
830
8529
40
203
849
8680
28
31
861
8852
—
31
22
849
8844
51
208
800
8456
94
629
649
6982
Infectious Disease
44 [38004484]
44 [38004484]
4.1e-01
1.1e+00
2.0e+00
—
2.5e+00
1.1e+00
8.5e-01
cases:2.25%
controls:1.51%
cases:1.80%
controls:0.63%
cases:0.67%
controls:0.09%
—
—
cases:1.14%
controls:0.09%
cases:1.88%
controls:0.62%
cases:3.90%
controls:1.71%
20
134
867
8723
16
56
873
8827
6
8
883
8875
—
10
8
870
8858
16
54
835
8610
29
130
714
7481
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
1.1e+00
1.2e+00
—
—
3.0e+00
1.3e+00
9.1e-01
cases:2.59%
controls:0.86%
cases:1.69%
controls:0.50%
—
—
—
—
cases:1.14%
controls:0.06%
cases:2.94%
controls:0.82%
cases:5.52%
controls:2.29%
23
76
864
8781
15
44
874
8839
—
—
10
5
870
8861
25
71
826
8593
41
174
702
7437
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
3.1e-01
5.5e-01
1.1e+00
3.1e+00
1.5e+00
8.2e-01
5.2e-01
cases:10.94%
controls:8.29%
cases:7.42%
controls:4.42%
cases:2.81%
controls:0.95%
cases:1.24%
controls:0.06%
cases:4.09%
controls:0.98%
cases:9.28%
controls:4.33%
cases:18.03%
controls:11.56%
97
734
790
8123
66
393
823
8490
25
84
864
8799
11
5
878
8878
36
87
844
8779
79
375
772
8289
134
880
609
6731
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
7.3e-01
6.3e-01
2.3e+00
1.0e+50
2.6e+00
1.2e+00
7.4e-01
cases:6.43%
controls:3.22%
cases:2.14%
controls:1.15%
cases:1.12%
controls:0.11%
cases:3.71%
controls:0.00%
cases:1.59%
controls:0.12%
cases:3.41%
controls:1.06%
cases:9.42%
controls:4.74%
57
285
830
8572
19
102
870
8781
10
10
879
8873
33
0
856
8883
14
11
866
8855
29
92
822
8572
70
361
673
7250
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
3.2e-01
2.6e-01
1.7e+00
—
3.9e+00
1.3e+00
6.2e-01
cases:4.62%
controls:3.39%
cases:2.25%
controls:1.74%
cases:0.90%
controls:0.17%
—
—
cases:7.61%
controls:0.17%
cases:4.47%
controls:1.30%
cases:7.81%
controls:4.38%
41
300
846
8557
20
155
869
8728
8
15
881
8868
—
67
15
813
8851
38
113
813
8551
58
333
685
7278
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
1.8e-01
2.5e-01
9.6e-01
3.9e+00
1.7e+00
5.3e-01
2.9e-01
cases:22.55%
controls:19.57%
cases:19.91%
controls:16.17%
cases:9.45%
controls:3.83%
cases:10.01%
controls:0.21%
cases:17.61%
controls:3.81%
cases:25.26%
controls:16.59%
cases:36.61%
controls:30.19%
200
1733
687
7124
177
1436
712
7447
84
340
805
8543
89
19
800
8864
155
338
725
8528
215
1437
636
7227
272
2298
471
5313
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
7.2e-01
1.5e+00
—
—
3.9e+00
2.0e+00
4.2e-01
cases:1.24%
controls:0.61%
cases:1.24%
controls:0.29%
—
—
—
—
cases:2.61%
controls:0.06%
cases:1.76%
controls:0.23%
cases:1.75%
controls:1.16%
11
54
876
8803
11
26
878
8857
—
—
23
5
857
8861
15
20
836
8644
13
88
730
7523
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
1.1e+00
1.2e+00
—
—
2.9e+00
1.2e+00
9.5e-01
cases:2.59%
controls:0.90%
cases:1.69%
controls:0.51%
—
—
—
—
cases:1.02%
controls:0.06%
cases:2.70%
controls:0.85%
cases:5.52%
controls:2.21%
23
80
864
8777
15
45
874
8838
—
—
9
5
871
8861
23
74
828
8590
41
168
702
7443
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
7.8e-01
1.0e+00
—
1.0e+50
3.2e+00
1.4e+00
9.0e-01
cases:3.61%
controls:1.69%
cases:1.69%
controls:0.61%
—
—
cases:5.85%
controls:0.00%
cases:1.59%
controls:0.07%
cases:1.88%
controls:0.46%
cases:3.77%
controls:1.56%
32
150
855
8707
15
54
874
8829
—
52
0
837
8883
14
6
866
8860
16
40
835
8624
28
119
715
7492
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
1.0e-01
2.9e-01
1.7e+00
—
3.7e+00
1.3e+00
6.3e-01
cases:5.64%
controls:5.13%
cases:3.04%
controls:2.30%
cases:1.24%
controls:0.24%
—
—
cases:8.75%
controls:0.25%
cases:5.99%
controls:1.72%
cases:10.36%
controls:5.79%
50
454
837
8403
27
204
862
8679
11
21
878
8862
—
77
22
803
8844
51
149
800
8515
77
441
666
7170
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
6.6e-01
1.5e+00
—
—
3.9e+00
1.9e+00
4.5e-01
cases:1.13%
controls:0.59%
cases:1.35%
controls:0.32%
—
—
—
—
cases:2.61%
controls:0.06%
cases:1.76%
controls:0.27%
cases:1.88%
controls:1.21%
10
52
877
8805
12
28
877
8855
—
—
23
5
857
8861
15
23
836
8641
14
92
729
7519
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
6.2e-01
1.4e+00
—
—
3.9e+00
2.0e+00
2.8e-01
cases:1.13%
controls:0.61%
cases:1.24%
controls:0.32%
—
—
—
—
cases:2.61%
controls:0.06%
cases:1.88%
controls:0.27%
cases:1.62%
controls:1.22%
10
54
877
8803
11
28
878
8855
—
—
23
5
857
8861
16
23
835
8641
12
93
731
7518
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
5.3e-01
5.7e-01
2.3e+00
—
2.7e+00
9.7e-01
6.8e-01
cases:6.54%
controls:3.97%
cases:3.60%
controls:2.06%
cases:1.69%
controls:0.17%
—
—
cases:3.07%
controls:0.21%
cases:4.11%
controls:1.59%
cases:11.04%
controls:5.91%
58
352
829
8505
32
183
857
8700
15
15
874
8868
—
27
19
853
8847
35
138
816
8526
82
450
661
7161
Psychiatric treatment plan, standard
ICB01 [2001304098]
ICB01 [2001304098]
1.8e+00
1.7e+00
—
—
—
2.2e+00
1.4e+00
cases:0.90%
controls:0.15%
cases:0.90%
controls:0.16%
—
—
—
—
—
—
cases:1.41%
controls:0.16%
cases:1.35%
controls:0.34%
8
13
879
8844
8
14
881
8869
—
—
—
12
14
839
8650
10
26
733
7585
Outpatient Visit
OP [9202]
OP [9202]
2.1e-01
2.1e-01
4.5e-01
3.4e+00
1.8e+00
9.5e-01
5.4e-01
cases:69.90%
controls:65.42%
cases:50.62%
controls:45.29%
cases:15.07%
controls:10.18%
cases:13.27%
controls:0.51%
cases:40.80%
controls:10.32%
cases:67.33%
controls:44.45%
cases:82.50%
controls:73.35%
620
5794
267
3063
450
4023
439
4860
134
904
755
7979
118
45
771
8838
359
915
521
7951
573
3851
278
4813
613
5583
130
2028
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
4.8e-01
4.9e-01
1.7e+00
—
2.6e+00
1.5e+00
8.5e-01
cases:13.08%
controls:8.48%
cases:4.27%
controls:2.66%
cases:2.02%
controls:0.39%
—
—
cases:6.59%
controls:0.51%
cases:8.70%
controls:2.08%
cases:14.00%
controls:6.53%
116
751
771
8106
38
236
851
8647
18
35
871
8848
—
58
45
822
8821
74
180
777
8484
104
497
639
7114
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
5.7e-01
6.0e-01
1.4e+00
—
2.6e+00
9.7e-01
9.0e-01
cases:11.05%
controls:6.55%
cases:4.84%
controls:2.72%
cases:2.14%
controls:0.53%
—
—
cases:6.02%
controls:0.47%
cases:6.23%
controls:2.45%
cases:14.54%
controls:6.44%
98
580
789
8277
43
242
846
8641
19
47
870
8836
—
53
42
827
8824
53
212
798
8452
108
490
635
7121
levomepromazine; oral, parenteral
N05AA02 [21604493]
N05AA02 [21604493]
1.6e+00
1.8e+00
—
—
—
1.9e+00
1.7e+00
cases:2.25%
controls:0.45%
cases:1.12%
controls:0.18%
—
—
—
—
—
—
cases:1.29%
controls:0.20%
cases:2.02%
controls:0.38%
20
40
867
8817
10
16
879
8867
—
—
—
11
17
840
8647
15
29
728
7582
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
7.4e-01
7.2e-01
—
—
3.9e+00
2.0e+00
1.2e+00
cases:2.82%
controls:1.37%
cases:1.12%
controls:0.55%
—
—
—
—
cases:4.09%
controls:0.09%
cases:3.29%
controls:0.47%
cases:4.98%
controls:1.56%
25
121
862
8736
10
49
879
8834
—
—
36
8
844
8858
28
41
823
8623
37
119
706
7492
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
1.1e-01
2.5e-01
8.6e-01
3.9e+00
9.5e-01
8.0e-01
4.2e-01
cases:8.79%
controls:7.91%
cases:5.62%
controls:4.44%
cases:3.15%
controls:1.35%
cases:2.81%
controls:0.06%
cases:3.75%
controls:1.48%
cases:8.46%
controls:3.98%
cases:14.54%
controls:10.04%
78
701
809
8156
50
394
839
8489
28
120
861
8763
25
5
864
8878
33
131
847
8735
72
345
779
8319
108
764
635
6847
Alcohol depence active use
F10.24 [2000501681]
F10.24 [2000501681]
2.8e+00
—
—
—
—
2.5e+00
1.6e+00
cases:0.90%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.06%
cases:1.08%
controls:0.21%
8
5
879
8852
—
—
—
—
6
5
845
8659
8
16
735
7595
Mixed anxiety and depressive disorder
F41.2 [45566845]
F41.2 [45566845]
1.2e+00
1.4e+00
1.6e+00
—
2.1e+00
1.4e+00
9.5e-01
cases:2.71%
controls:0.86%
cases:1.35%
controls:0.35%
cases:0.56%
controls:0.11%
—
—
cases:0.80%
controls:0.10%
cases:1.29%
controls:0.33%
cases:3.77%
controls:1.50%
24
76
863
8781
12
31
877
8852
5
10
884
8873
—
7
9
873
8857
11
29
840
8635
28
114
715
7497
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
5.0e-01
8.2e-01
2.2e+00
—
3.1e+00
1.6e+00
5.0e-01
cases:2.48%
controls:1.52%
cases:2.02%
controls:0.90%
cases:0.67%
controls:0.08%
—
—
cases:2.95%
controls:0.14%
cases:3.41%
controls:0.73%
cases:4.44%
controls:2.75%
22
135
865
8722
18
80
871
8803
6
7
883
8876
—
26
12
854
8854
29
63
822
8601
33
209
710
7402
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.0e-01
1.6e-01
9.2e-01
3.9e+00
1.6e+00
4.1e-01
2.3e-01
cases:29.65%
controls:27.62%
cases:25.76%
controls:22.80%
cases:11.25%
controls:4.82%
cases:12.37%
controls:0.28%
cases:20.23%
controls:4.92%
cases:31.61%
controls:23.48%
cases:47.51%
controls:41.93%
263
2446
624
6411
229
2025
660
6858
100
428
789
8455
110
25
779
8858
178
436
702
8430
269
2034
582
6630
353
3191
390
4420
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
6.3e-01
1.0e+00
—
1.0e+50
3.9e+00
1.8e+00
5.5e-01
cases:3.61%
controls:1.95%
cases:1.80%
controls:0.64%
—
—
cases:0.90%
controls:0.00%
cases:5.00%
controls:0.10%
cases:4.00%
controls:0.66%
cases:4.17%
controls:2.46%
32
173
855
8684
16
57
873
8826
—
8
0
881
8883
44
9
836
8857
34
57
817
8607
31
187
712
7424
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
6.6e-01
9.3e-01
1.5e+00
—
1.9e+00
9.2e-01
8.1e-01
cases:7.33%
controls:3.93%
cases:4.72%
controls:1.93%
cases:1.46%
controls:0.33%
—
—
cases:1.70%
controls:0.25%
cases:5.29%
controls:2.17%
cases:11.57%
controls:5.51%
65
348
822
8509
42
171
847
8712
13
29
876
8854
—
15
22
865
8844
45
188
806
8476
86
419
657
7192
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
1.1e+00
1.1e+00
—
—
2.7e+00
2.0e+00
9.6e-01
cases:3.27%
controls:1.14%
cases:1.24%
controls:0.42%
—
—
—
—
cases:1.02%
controls:0.07%
cases:2.35%
controls:0.32%
cases:3.77%
controls:1.47%
29
101
858
8756
11
37
878
8846
—
—
9
6
871
8860
20
28
831
8636
28
112
715
7499
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
6.7e-01
1.2e+00
—
—
4.0e+00
1.5e+00
2.9e-01
cases:1.69%
controls:0.87%
cases:1.57%
controls:0.46%
—
—
—
—
cases:3.07%
controls:0.06%
cases:1.88%
controls:0.43%
cases:2.69%
controls:2.02%
15
77
872
8780
14
41
875
8842
—
—
27
5
853
8861
16
37
835
8627
20
154
723
7457
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
6.4e-01
7.8e-01
2.2e+00
—
2.8e+00
9.9e-01
5.5e-01
cases:4.06%
controls:2.19%
cases:2.59%
controls:1.20%
cases:1.24%
controls:0.14%
—
—
cases:3.18%
controls:0.19%
cases:2.59%
controls:0.98%
cases:4.71%
controls:2.77%
36
194
851
8663
23
107
866
8776
11
12
878
8871
—
28
17
852
8849
22
85
829
8579
35
211
708
7400
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
1.2e+00
1.2e+00
1.5e+00
—
7.4e-01
1.4e+00
1.3e+00
cases:6.76%
controls:2.24%
cases:4.27%
controls:1.27%
cases:1.12%
controls:0.25%
—
—
cases:0.68%
controls:0.33%
cases:4.11%
controls:1.04%
cases:6.73%
controls:1.92%
60
198
827
8659
38
113
851
8770
10
22
879
8861
—
6
29
874
8837
35
90
816
8574
50
146
693
7465
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
1.4e-01
2.5e-01
8.3e-01
3.8e+00
1.6e+00
4.4e-01
1.2e-01
cases:26.16%
controls:23.62%
cases:22.05%
controls:18.03%
cases:9.00%
controls:4.13%
cases:10.01%
controls:0.26%
cases:17.50%
controls:4.09%
cases:26.56%
controls:18.89%
cases:38.63%
controls:35.79%
232
2092
655
6765
196
1602
693
7281
80
367
809
8516
89
23
800
8860
154
363
726
8503
226
1637
625
7027
287
2724
456
4887
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
6.7e-02
1.7e-01
9.0e-01
3.8e+00
1.5e+00
3.9e-01
1.7e-01
cases:32.47%
controls:31.03%
cases:29.13%
controls:25.82%
cases:13.05%
controls:5.75%
cases:13.05%
controls:0.34%
cases:22.05%
controls:5.84%
cases:35.02%
controls:26.73%
cases:50.47%
controls:46.34%
288
2748
599
6109
259
2294
630
6589
116
511
773
8372
116
30
773
8853
194
518
686
8348
298
2316
553
6348
375
3527
368
4084
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
6.9e-02
1.7e-01
9.0e-01
3.8e+00
1.5e+00
3.9e-01
1.6e-01
cases:32.58%
controls:31.08%
cases:29.25%
controls:25.87%
cases:13.05%
controls:5.73%
cases:13.05%
controls:0.34%
cases:22.05%
controls:5.87%
cases:35.02%
controls:26.78%
cases:50.47%
controls:46.43%
289
2753
598
6104
260
2298
629
6585
116
509
773
8374
116
30
773
8853
194
520
686
8346
298
2320
553
6344
375
3534
368
4077
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
ZXE11 [2001311402]
1.2e+00
6.4e-01
—
1.0e+50
2.5e+00
1.6e+00
1.3e+00
cases:2.25%
controls:0.67%
cases:0.79%
controls:0.42%
—
—
cases:0.79%
controls:0.00%
cases:0.80%
controls:0.07%
cases:1.29%
controls:0.28%
cases:1.48%
controls:0.39%
20
59
867
8798
7
37
882
8846
—
7
0
882
8883
7
6
873
8860
11
24
840
8640
11
30
732
7581
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
6.6e-02
1.7e-01
9.0e-01
3.8e+00
1.5e+00
3.9e-01
1.6e-01
cases:32.58%
controls:31.14%
cases:29.25%
controls:25.93%
cases:13.05%
controls:5.75%
cases:13.05%
controls:0.34%
cases:22.05%
controls:5.88%
cases:35.02%
controls:26.81%
cases:50.47%
controls:46.46%
289
2758
598
6099
260
2303
629
6580
116
511
773
8372
116
30
773
8853
194
521
686
8345
298
2323
553
6341
375
3536
368
4075
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
6.7e-02
1.7e-01
9.0e-01
3.8e+00
1.5e+00
3.8e-01
1.6e-01
cases:32.58%
controls:31.13%
cases:29.25%
controls:25.91%
cases:13.05%
controls:5.75%
cases:13.05%
controls:0.34%
cases:22.05%
controls:5.87%
cases:34.90%
controls:26.79%
cases:50.47%
controls:46.45%
289
2757
598
6100
260
2302
629
6581
116
511
773
8372
116
30
773
8853
194
520
686
8346
297
2321
554
6343
375
3535
368
4076
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
3.6e-02
1.1e-01
8.5e-01
3.8e+00
1.6e+00
3.9e-01
1.2e-01
cases:26.94%
controls:26.25%
cases:19.46%
controls:17.83%
cases:7.42%
controls:3.31%
cases:7.99%
controls:0.20%
cases:13.98%
controls:3.24%
cases:24.09%
controls:17.64%
cases:39.43%
controls:36.57%
239
2325
648
6532
173
1584
716
7299
66
294
823
8589
71
18
818
8865
123
287
757
8579
205
1528
646
7136
293
2783
450
4828
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
6.5e-02
1.7e-01
9.0e-01
3.8e+00
1.5e+00
3.9e-01
1.6e-01
cases:32.58%
controls:31.16%
cases:29.25%
controls:25.91%
cases:13.05%
controls:5.75%
cases:12.94%
controls:0.34%
cases:22.05%
controls:5.89%
cases:35.02%
controls:26.78%
cases:50.47%
controls:46.49%
289
2760
598
6097
260
2302
629
6581
116
511
773
8372
115
30
774
8853
194
522
686
8344
298
2320
553
6344
375
3538
368
4073
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
6.3e-02
1.6e-01
9.0e-01
3.8e+00
1.5e+00
3.8e-01
1.6e-01
cases:32.58%
controls:31.22%
cases:29.13%
controls:25.94%
cases:13.05%
controls:5.76%
cases:13.05%
controls:0.34%
cases:22.05%
controls:5.91%
cases:34.90%
controls:26.79%
cases:50.61%
controls:46.55%
289
2765
598
6092
259
2304
630
6579
116
512
773
8371
116
30
773
8853
194
524
686
8342
297
2321
554
6343
376
3543
367
4068
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
6.4e-02
1.6e-01
9.0e-01
3.8e+00
1.5e+00
3.8e-01
1.6e-01
cases:32.58%
controls:31.18%
cases:29.25%
controls:25.96%
cases:13.05%
controls:5.78%
cases:13.05%
controls:0.34%
cases:22.05%
controls:5.92%
cases:35.02%
controls:26.88%
cases:50.47%
controls:46.54%
289
2762
598
6095
260
2306
629
6577
116
513
773
8370
116
30
773
8853
194
525
686
8341
298
2329
553
6335
375
3542
368
4069
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
6.4e-01
9.7e-01
2.0e+00
—
1.7e+00
7.2e-01
5.0e-01
cases:5.86%
controls:3.17%
cases:3.82%
controls:1.49%
cases:1.24%
controls:0.17%
—
—
cases:1.25%
controls:0.23%
cases:3.53%
controls:1.74%
cases:9.96%
controls:6.31%
52
281
835
8576
34
132
855
8751
11
15
878
8868
—
11
20
869
8846
30
151
821
8513
74
480
669
7131
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
N02AE01 [21604287]
1.0e+00
1.1e+00
2.0e+00
—
1.1e+00
1.4e+00
1.0e+00
cases:2.71%
controls:0.99%
cases:1.91%
controls:0.62%
cases:1.46%
controls:0.20%
—
—
cases:0.80%
controls:0.26%
cases:2.59%
controls:0.65%
cases:3.90%
controls:1.47%
24
88
863
8769
17
55
872
8828
13
18
876
8865
—
7
23
873
8843
22
56
829
8608
29
112
714
7499
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
F32.2 [45557202]
1.2e+00
1.5e+00
2.2e+00
—
—
1.7e+00
8.5e-01
cases:2.25%
controls:0.72%
cases:1.24%
controls:0.28%
cases:0.67%
controls:0.08%
—
—
—
—
cases:1.41%
controls:0.25%
cases:1.35%
controls:0.58%
20
64
867
8793
11
25
878
8858
6
7
883
8876
—
—
12
22
839
8642
10
44
733
7567
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
ZXE06 [2001311400]
9.2e-01
8.8e-01
—
1.0e+50
2.8e+00
2.1e+00
1.5e+00
cases:1.58%
controls:0.63%
cases:0.79%
controls:0.33%
—
—
cases:0.79%
controls:0.00%
cases:1.14%
controls:0.07%
cases:1.65%
controls:0.20%
cases:1.35%
controls:0.29%
14
56
873
8801
7
29
882
8854
—
7
0
882
8883
10
6
870
8860
14
17
837
8647
10
22
733
7589
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
4.9e-01
8.9e-01
2.6e+00
—
2.7e+00
1.1e+00
5.7e-01
cases:5.41%
controls:3.38%
cases:2.02%
controls:0.84%
cases:0.79%
controls:0.06%
—
—
cases:1.36%
controls:0.09%
cases:2.59%
controls:0.84%
cases:5.38%
controls:3.13%
48
299
839
8558
18
75
871
8808
7
5
882
8878
—
12
8
868
8858
22
73
829
8591
40
238
703
7373
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
5.6e-01
1.1e+00
—
—
3.8e+00
1.6e+00
3.2e-01
cases:1.69%
controls:0.97%
cases:1.69%
controls:0.59%
—
—
—
—
cases:2.84%
controls:0.07%
cases:2.12%
controls:0.43%
cases:2.96%
controls:2.17%
15
86
872
8771
15
52
874
8831
—
—
25
6
855
8860
18
37
833
8627
22
165
721
7446
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
5.2e-01
6.2e-01
2.0e+00
1.0e+50
2.7e+00
1.0e+00
7.5e-01
cases:3.61%
controls:2.18%
cases:1.69%
controls:0.91%
cases:0.67%
controls:0.09%
cases:0.79%
controls:0.00%
cases:0.80%
controls:0.06%
cases:2.12%
controls:0.78%
cases:4.98%
controls:2.42%
32
193
855
8664
15
81
874
8802
6
8
883
8875
7
0
882
8883
7
5
873
8861
18
68
833
8596
37
184
706
7427
Laceration/cut
S18 [2002000983]
S18 [2002000983]
3.9e-01
5.4e-01
1.7e+00
—
3.0e+00
1.2e+00
5.1e-01
cases:9.36%
controls:6.50%
cases:4.27%
controls:2.54%
cases:1.91%
controls:0.34%
—
—
cases:4.09%
controls:0.21%
cases:6.58%
controls:2.17%
cases:12.25%
controls:7.77%
83
576
804
8281
38
226
851
8657
17
30
872
8853
—
36
19
844
8847
56
188
795
8476
91
591
652
7020
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
7.1e-01
1.1e+00
—
—
3.7e+00
1.5e+00
5.3e-01
cases:2.25%
controls:1.12%
cases:1.91%
controls:0.65%
—
—
—
—
cases:3.18%
controls:0.08%
cases:2.23%
controls:0.51%
cases:3.90%
controls:2.34%
20
99
867
8758
17
58
872
8825
—
—
28
7
852
8859
19
44
832
8620
29
178
714
7433
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
6.7e-01
1.1e+00
—
—
3.7e+00
1.5e+00
5.4e-01
cases:2.14%
controls:1.11%
cases:1.91%
controls:0.66%
—
—
—
—
cases:3.18%
controls:0.08%
cases:2.12%
controls:0.50%
cases:3.90%
controls:2.31%
19
98
868
8759
17
59
872
8824
—
—
28
7
852
8859
18
43
833
8621
29
176
714
7435
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
6.7e-01
1.1e+00
—
—
3.7e+00
1.5e+00
5.4e-01
cases:2.14%
controls:1.11%
cases:1.91%
controls:0.66%
—
—
—
—
cases:3.18%
controls:0.08%
cases:2.12%
controls:0.50%
cases:3.90%
controls:2.31%
19
98
868
8759
17
59
872
8824
—
—
28
7
852
8859
18
43
833
8621
29
176
714
7435
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
6.2e-01
8.5e-01
1.5e+00
—
1.7e+00
8.4e-01
7.4e-01
cases:7.22%
controls:4.03%
cases:4.84%
controls:2.13%
cases:1.46%
controls:0.34%
—
—
cases:1.70%
controls:0.30%
cases:5.29%
controls:2.35%
cases:11.44%
controls:5.78%
64
357
823
8500
43
189
846
8694
13
30
876
8853
—
15
27
865
8839
45
204
806
8460
85
440
658
7171
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
-9.8e-03
2.2e-01
9.1e-01
4.0e+00
1.3e+00
2.2e-01
1.3e-01
cases:12.63%
controls:12.74%
cases:7.76%
controls:6.32%
cases:2.36%
controls:0.97%
cases:2.92%
controls:0.06%
cases:3.75%
controls:1.00%
cases:8.23%
controls:6.74%
cases:19.11%
controls:17.16%
112
1128
775
7729
69
561
820
8322
21
86
868
8797
26
5
863
8878
33
89
847
8777
70
584
781
8080
142
1306
601
6305
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
7.3e-01
1.0e+00
—
—
3.7e+00
1.5e+00
5.0e-01
cases:2.25%
controls:1.10%
cases:1.91%
controls:0.69%
—
—
—
—
cases:3.07%
controls:0.08%
cases:2.12%
controls:0.50%
cases:3.77%
controls:2.31%
20
97
867
8760
17
61
872
8822
—
—
27
7
853
8859
18
43
833
8621
28
176
715
7435
Exposure to other specified factors
X58 [45756411]
X58 [45756411]
1.0e+00
1.5e+00
—
1.0e+50
—
2.3e+00
1.2e+00
cases:4.06%
controls:1.51%
cases:2.14%
controls:0.47%
—
—
cases:5.96%
controls:0.00%
—
—
cases:4.00%
controls:0.40%
cases:6.06%
controls:1.85%
36
134
851
8723
19
42
870
8841
—
53
0
836
8883
—
34
35
817
8629
45
141
698
7470
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
1.8e-01
3.8e-01
8.8e-01
2.4e+00
1.2e+00
5.9e-01
4.9e-01
cases:17.59%
controls:15.13%
cases:13.16%
controls:9.37%
cases:4.05%
controls:1.72%
cases:1.24%
controls:0.11%
cases:5.80%
controls:1.88%
cases:15.39%
controls:9.14%
cases:29.88%
controls:20.63%
156
1340
731
7517
117
832
772
8051
36
153
853
8730
11
10
878
8873
51
167
829
8699
131
792
720
7872
222
1570
521
6041
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
5.6e-01
7.2e-01
1.3e+00
—
1.8e+00
8.7e-01
7.1e-01
cases:7.89%
controls:4.67%
cases:5.29%
controls:2.63%
cases:1.57%
controls:0.44%
—
—
cases:1.82%
controls:0.32%
cases:6.11%
controls:2.65%
cases:13.32%
controls:7.00%
70
414
817
8443
47
234
842
8649
14
39
875
8844
—
16
28
864
8838
52
230
799
8434
99
533
644
7078
clonazepam; oral, parenteral
N03AE01 [21604415]
N03AE01 [21604415]
7.7e-01
1.4e+00
2.0e+00
—
—
1.3e+00
1.1e+00
cases:1.58%
controls:0.73%
cases:1.57%
controls:0.38%
cases:0.67%
controls:0.09%
—
—
—
—
cases:1.53%
controls:0.44%
cases:2.15%
controls:0.70%
14
65
873
8792
14
34
875
8849
6
8
883
8875
—
—
13
38
838
8626
16
53
727
7558
Major dressing of wound of skin of trunk
QBB10 [2001309842]
QBB10 [2001309842]
8.2e-01
2.0e+00
—
1.0e+50
1.0e+50
3.8e+00
1.7e+00
cases:0.56%
controls:0.25%
cases:0.67%
controls:0.09%
—
—
cases:1.01%
controls:0.00%
cases:2.73%
controls:0.00%
cases:2.59%
controls:0.06%
cases:0.81%
controls:0.14%
5
22
882
8835
6
8
883
8875
—
9
0
880
8883
24
0
856
8866
22
5
829
8659
6
11
737
7600
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
5.4e-01
1.0e+00
2.2e+00
—
—
1.5e+00
1.1e+00
cases:2.93%
controls:1.73%
cases:1.57%
controls:0.56%
cases:0.79%
controls:0.09%
—
—
—
—
cases:2.23%
controls:0.52%
cases:3.63%
controls:1.18%
26
153
861
8704
14
50
875
8833
7
8
882
8875
—
—
19
45
832
8619
27
90
716
7521
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
7.9e-01
8.1e-01
1.3e+00
—
2.2e+00
1.0e+00
9.9e-01
cases:3.95%
controls:1.83%
cases:2.59%
controls:1.17%
cases:0.79%
controls:0.23%
—
—
cases:1.25%
controls:0.14%
cases:3.53%
controls:1.33%
cases:9.02%
controls:3.56%
35
162
852
8695
23
104
866
8779
7
20
882
8863
—
11
12
869
8854
30
115
821
8549
67
271
676
7340
Orthopedic Surgery
20 [38004465]
20 [38004465]
5.0e-01
7.6e-01
1.4e+00
—
1.6e+00
9.2e-01
6.1e-01
cases:18.15%
controls:11.86%
cases:9.11%
controls:4.48%
cases:2.59%
controls:0.66%
—
—
cases:3.64%
controls:0.72%
cases:9.99%
controls:4.25%
cases:22.75%
controls:13.82%
161
1050
726
7807
81
398
808
8485
23
59
866
8824
—
32
64
848
8802
85
368
766
8296
169
1052
574
6559
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.6e-02
1.3e-01
6.6e-01
3.6e+00
1.2e+00
3.2e-01
3.8e-02
cases:36.19%
controls:35.82%
cases:36.11%
controls:33.15%
cases:18.34%
controls:10.42%
cases:16.65%
controls:0.54%
cases:27.16%
controls:10.47%
cases:42.07%
controls:34.51%
cases:52.62%
controls:51.69%
321
3173
566
5684
321
2945
568
5938
163
926
726
7957
148
48
741
8835
239
928
641
7938
358
2990
493
5674
391
3934
352
3677
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
7.8e-01
8.3e-01
1.4e+00
—
2.1e+00
1.0e+00
9.3e-01
cases:3.61%
controls:1.68%
cases:2.47%
controls:1.09%
cases:0.90%
controls:0.23%
—
—
cases:1.14%
controls:0.14%
cases:3.64%
controls:1.33%
cases:9.29%
controls:3.88%
32
149
855
8708
22
97
867
8786
8
20
881
8863
—
10
12
870
8854
31
115
820
8549
69
295
674
7316
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
4.5e-01
9.2e-01
—
1.0e+50
3.4e+00
1.3e+00
1.0e+00
cases:4.51%
controls:2.91%
cases:1.46%
controls:0.59%
—
—
cases:1.24%
controls:0.00%
cases:2.84%
controls:0.10%
cases:2.00%
controls:0.57%
cases:6.46%
controls:2.36%
40
258
847
8599
13
52
876
8831
—
11
0
878
8883
25
9
855
8857
17
49
834
8615
48
180
695
7431
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
6.1e-01
6.4e-01
1.6e+00
—
2.9e+00
1.2e+00
4.5e-01
cases:3.95%
controls:2.19%
cases:2.59%
controls:1.38%
cases:1.24%
controls:0.26%
—
—
cases:3.75%
controls:0.21%
cases:3.64%
controls:1.15%
cases:4.58%
controls:2.96%
35
194
852
8663
23
123
866
8760
11
23
878
8860
—
33
19
847
8847
31
100
820
8564
34
225
709
7386
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
5.8e-01
7.2e-01
1.4e+00
1.0e+50
2.9e+00
1.4e+00
7.5e-01
cases:7.78%
controls:4.52%
cases:2.70%
controls:1.33%
cases:0.67%
controls:0.17%
cases:2.81%
controls:0.00%
cases:2.16%
controls:0.12%
cases:3.29%
controls:0.83%
cases:5.25%
controls:2.56%
69
400
818
8457
24
118
865
8765
6
15
883
8868
25
0
864
8883
19
11
861
8855
28
72
823
8592
39
195
704
7416
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
3.4e-01
7.4e-01
—
—
3.4e+00
1.2e+00
9.2e-01
cases:2.14%
controls:1.54%
cases:1.69%
controls:0.81%
—
—
—
—
cases:2.73%
controls:0.09%
cases:2.59%
controls:0.76%
cases:6.33%
controls:2.61%
19
136
868
8721
15
72
874
8811
—
—
24
8
856
8858
22
66
829
8598
47
199
696
7412
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
6.6e-01
9.7e-01
—
1.0e+50
2.7e+00
1.1e+00
8.2e-01
cases:2.82%
controls:1.48%
cases:1.80%
controls:0.69%
—
—
cases:0.56%
controls:0.00%
cases:1.14%
controls:0.08%
cases:3.53%
controls:1.21%
cases:6.46%
controls:2.96%
25
131
862
8726
16
61
873
8822
—
5
0
884
8883
10
7
870
8859
30
105
821
8559
48
225
695
7386
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
5.2e-01
7.1e-01
1.3e+00
—
1.6e+00
8.4e-01
5.7e-01
cases:8.46%
controls:5.20%
cases:6.07%
controls:3.10%
cases:1.91%
controls:0.52%
—
—
cases:2.16%
controls:0.44%
cases:7.05%
controls:3.19%
cases:14.13%
controls:8.51%
75
461
812
8396
54
275
835
8608
17
46
872
8837
—
19
39
861
8827
60
276
791
8388
105
648
638
6963
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
3.3e-01
6.3e-01
1.6e+00
—
1.8e+00
6.7e-01
5.0e-01
cases:16.01%
controls:12.09%
cases:8.66%
controls:4.83%
cases:3.37%
controls:0.73%
—
—
cases:4.55%
controls:0.74%
cases:8.58%
controls:4.59%
cases:19.11%
controls:12.56%
142
1071
745
7786
77
429
812
8454
30
65
859
8818
—
40
66
840
8800
73
398
778
8266
142
956
601
6655
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46083-2 [3043362]
46083-2 [3043362]
1.2e+00
—
—
—
—
2.2e+00
2.0e+00
cases:1.35%
controls:0.41%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.12%
cases:1.48%
controls:0.20%
12
36
875
8821
—
—
—
—
9
10
842
8654
11
15
732
7596
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46082-4 [3046524]
46082-4 [3046524]
1.2e+00
—
—
—
—
2.2e+00
2.0e+00
cases:1.35%
controls:0.41%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.12%
cases:1.48%
controls:0.20%
12
36
875
8821
—
—
—
—
9
10
842
8654
11
15
732
7596
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
IEY05 [2001304224]
2.0e+00
1.6e+00
—
—
2.0e+00
1.8e+00
1.1e+00
cases:1.24%
controls:0.17%
cases:1.01%
controls:0.20%
—
—
—
—
cases:0.57%
controls:0.08%
cases:1.76%
controls:0.30%
cases:1.62%
controls:0.53%
11
15
876
8842
9
18
880
8865
—
—
5
7
875
8859
15
26
836
8638
12
40
731
7571
Severe psychotic and other severe mental disorders
112 [2001600112]
112 [2001600112]
1.1e+00
—
—
—
—
2.1e+00
2.2e+00
cases:1.58%
controls:0.52%
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.12%
cases:2.15%
controls:0.25%
14
46
873
8811
—
—
—
—
8
10
843
8654
16
19
727
7592
Participation in compiling a psychiatric treatment plan
ICZ03 [2001304119]
ICZ03 [2001304119]
1.8e+00
1.6e+00
1.8e+00
—
—
2.0e+00
1.3e+00
cases:1.24%
controls:0.20%
cases:1.01%
controls:0.20%
cases:0.56%
controls:0.09%
—
—
—
—
cases:1.06%
controls:0.15%
cases:1.35%
controls:0.38%
11
18
876
8839
9
18
880
8865
5
8
884
8875
—
—
9
13
842
8651
10
29
733
7582
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
4.7e-01
7.1e-01
1.2e+00
—
1.6e+00
7.0e-01
6.4e-01
cases:8.57%
controls:5.51%
cases:5.85%
controls:2.96%
cases:1.57%
controls:0.48%
—
—
cases:1.93%
controls:0.41%
cases:5.99%
controls:3.08%
cases:14.00%
controls:7.88%
76
488
811
8369
52
263
837
8620
14
43
875
8840
—
17
36
863
8830
51
267
800
8397
104
600
639
7011
disulfiram; oral
N07BB01 [21604821]
N07BB01 [21604821]
1.3e+00
1.6e+00
—
—
—
2.2e+00
1.7e+00
cases:2.03%
controls:0.54%
cases:0.79%
controls:0.16%
—
—
—
—
—
—
cases:1.29%
controls:0.14%
cases:3.10%
controls:0.58%
18
48
869
8809
7
14
882
8869
—
—
—
11
12
840
8652
23
44
720
7567
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
3.6e-01
9.6e-01
—
1.0e+50
2.5e+00
1.4e+00
1.3e+00
cases:4.06%
controls:2.86%
cases:1.46%
controls:0.56%
—
—
cases:1.69%
controls:0.00%
cases:0.91%
controls:0.08%
cases:1.76%
controls:0.43%
cases:4.17%
controls:1.12%
36
253
851
8604
13
50
876
8833
—
15
0
874
8883
8
7
872
8859
15
37
836
8627
31
85
712
7526
Psychological sympt/compl other
P29 [2002000823]
P29 [2002000823]
1.0e+00
1.4e+00
—
—
—
1.9e+00
9.2e-01
cases:2.03%
controls:0.73%
cases:1.24%
controls:0.32%
—
—
—
—
—
—
cases:1.65%
controls:0.25%
cases:2.83%
controls:1.14%
18
65
869
8792
11
28
878
8855
—
—
—
14
22
837
8642
21
87
722
7524
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.1e-01
1.1e-01
5.3e-01
3.4e+00
9.9e-01
2.6e-01
1.2e-01
cases:58.96%
controls:56.18%
cases:52.08%
controls:49.36%
cases:29.58%
controls:19.76%
cases:26.88%
controls:1.20%
cases:39.32%
controls:19.41%
cases:57.70%
controls:51.15%
cases:71.60%
controls:69.06%
523
4976
364
3881
463
4385
426
4498
263
1755
626
7128
239
107
650
8776
346
1721
534
7145
491
4432
360
4232
532
5256
211
2355
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
1.3e+00
1.2e+00
1.3e+00
—
5.9e-01
1.3e+00
1.5e+00
cases:3.95%
controls:1.14%
cases:2.59%
controls:0.81%
cases:1.24%
controls:0.35%
—
—
cases:0.57%
controls:0.32%
cases:3.06%
controls:0.87%
cases:5.11%
controls:1.25%
35
101
852
8756
23
72
866
8811
11
31
878
8852
—
5
28
875
8838
26
75
825
8589
38
95
705
7516
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
OMOP4821991 [45756751]
1.2e+00
1.5e+00
—
1.0e+50
—
2.2e+00
1.7e+00
cases:2.03%
controls:0.60%
cases:0.90%
controls:0.20%
—
—
cases:1.12%
controls:0.00%
—
—
cases:1.65%
controls:0.18%
cases:2.15%
controls:0.39%
18
53
869
8804
8
18
881
8865
—
10
0
879
8883
—
14
16
837
8648
16
30
727
7581
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
19550-3 [3028707]
1.3e+00
1.9e+00
—
1.0e+50
—
1.6e+00
1.9e+00
cases:1.58%
controls:0.44%
cases:1.01%
controls:0.15%
—
—
cases:0.79%
controls:0.00%
—
—
cases:0.82%
controls:0.16%
cases:2.69%
controls:0.41%
14
39
873
8818
9
13
880
8870
—
7
0
882
8883
—
7
14
844
8650
20
31
723
7580
Addiction caused by alcohol UNS
F10.29 [2000501684]
F10.29 [2000501684]
1.5e+00
2.0e+00
—
—
—
—
1.7e+00
cases:1.13%
controls:0.26%
cases:0.79%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.20%
10
23
877
8834
7
10
882
8873
—
—
—
—
8
15
735
7596
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
19232-8 [3007628]
1.4e+00
1.2e+00
—
—
2.0e+00
1.6e+00
8.4e-01
cases:2.71%
controls:0.65%
cases:1.57%
controls:0.47%
—
—
—
—
cases:0.57%
controls:0.08%
cases:1.88%
controls:0.39%
cases:2.96%
controls:1.30%
24
58
863
8799
14
42
875
8841
—
—
5
7
875
8859
16
34
835
8630
22
99
721
7512
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
3.9e-01
4.8e-01
—
1.0e+50
3.7e+00
1.0e+00
1.3e+00
cases:5.07%
controls:3.50%
cases:1.69%
controls:1.05%
—
—
cases:4.84%
controls:0.00%
cases:2.61%
controls:0.07%
cases:1.53%
controls:0.57%
cases:6.19%
controls:1.72%
45
310
842
8547
15
93
874
8790
—
43
0
846
8883
23
6
857
8860
13
49
838
8615
46
131
697
7480
Difficulties in perfomrming procedure
ZXD30 [2001311389]
ZXD30 [2001311389]
4.3e-01
2.0e+00
—
1.0e+50
—
3.0e+00
—
cases:0.68%
controls:0.44%
cases:0.79%
controls:0.11%
—
—
cases:1.69%
controls:0.00%
—
—
cases:2.35%
controls:0.12%
—
—
6
39
881
8818
7
10
882
8873
—
15
0
874
8883
—
20
10
831
8654
—
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
8.4e-01
3.9e-01
1.5e+00
—
2.7e+00
1.4e+00
6.2e-01
cases:3.27%
controls:1.45%
cases:1.46%
controls:0.99%
cases:0.67%
controls:0.16%
—
—
cases:3.07%
controls:0.20%
cases:2.94%
controls:0.74%
cases:3.50%
controls:1.92%
29
128
858
8729
13
88
876
8795
6
14
883
8869
—
27
18
853
8848
25
64
826
8600
26
146
717
7465
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.2e-01
2.1e-01
6.2e-01
3.1e+00
9.7e-01
2.8e-01
1.8e-01
cases:28.86%
controls:26.39%
cases:23.85%
controls:20.24%
cases:6.64%
controls:3.67%
cases:2.92%
controls:0.14%
cases:9.43%
controls:3.79%
cases:25.73%
controls:20.80%
cases:44.68%
controls:40.23%
256
2337
631
6520
212
1798
677
7085
59
326
830
8557
26
12
863
8871
83
336
797
8530
219
1802
632
6862
332
3062
411
4549
Inpatient Visit
IP [9201]
IP [9201]
2.0e-01
4.8e-01
1.3e+00
1.0e+50
3.0e+00
1.4e+00
5.4e-01
cases:5.07%
controls:4.19%
cases:3.04%
controls:1.90%
cases:0.67%
controls:0.19%
cases:0.79%
controls:0.00%
cases:4.32%
controls:0.23%
cases:6.23%
controls:1.57%
cases:10.09%
controls:6.14%
45
371
842
8486
27
169
862
8714
6
17
883
8866
7
0
882
8883
38
20
842
8846
53
136
798
8528
75
467
668
7144
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
9.9e-01
1.0e+00
—
1.0e+50
2.8e+00
1.2e+00
1.2e+00
cases:1.69%
controls:0.63%
cases:0.90%
controls:0.33%
—
—
cases:0.67%
controls:0.00%
cases:0.91%
controls:0.06%
cases:1.29%
controls:0.40%
cases:3.90%
controls:1.25%
15
56
872
8801
8
29
881
8854
—
6
0
883
8883
8
5
872
8861
11
35
840
8629
29
95
714
7516
Alcohol-related acute intoxication uncomplicated
F10.00 [2000501668]
F10.00 [2000501668]
2.4e+00
—
—
—
—
—
2.5e+00
cases:1.13%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.21%
controls:0.11%
10
9
877
8848
—
—
—
—
—
9
8
734
7603
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
4.0e-01
5.6e-01
—
—
3.4e+00
1.4e+00
5.3e-01
cases:1.92%
controls:1.30%
cases:1.24%
controls:0.71%
—
—
—
—
cases:2.05%
controls:0.07%
cases:2.00%
controls:0.51%
cases:3.77%
controls:2.25%
17
115
870
8742
11
63
878
8820
—
—
18
6
862
8860
17
44
834
8620
28
171
715
7440
Bilateral
ZXA10 [2001311348]
ZXA10 [2001311348]
3.3e-01
3.0e-01
—
1.0e+50
3.2e+00
1.6e+00
3.0e-01
cases:3.04%
controls:2.21%
cases:0.79%
controls:0.59%
—
—
cases:2.92%
controls:0.00%
cases:1.59%
controls:0.07%
cases:2.12%
controls:0.43%
cases:2.02%
controls:1.50%
27
196
860
8661
7
52
882
8831
—
26
0
863
8883
14
6
866
8860
18
37
833
8627
15
114
728
7497
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
3.2e-01
6.0e-01
9.5e-01
1.0e+50
2.0e+00
1.9e+00
8.6e-01
cases:7.44%
controls:5.52%
cases:3.49%
controls:1.95%
cases:0.90%
controls:0.35%
cases:2.47%
controls:0.00%
cases:2.27%
controls:0.33%
cases:12.10%
controls:1.97%
cases:11.71%
controls:5.33%
66
489
821
8368
31
173
858
8710
8
31
881
8852
22
0
867
8883
20
29
860
8837
103
171
748
8493
87
406
656
7205
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
3.4e-01
3.8e-01
8.5e-01
—
1.9e+00
5.9e-01
5.5e-01
cases:34.61%
controls:27.40%
cases:19.57%
controls:14.30%
cases:5.51%
controls:2.43%
—
—
cases:14.55%
controls:2.37%
cases:22.68%
controls:14.02%
cases:46.03%
controls:32.93%
307
2427
580
6430
174
1270
715
7613
49
216
840
8667
—
128
210
752
8656
193
1215
658
7449
342
2506
401
5105
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
1.5e-01
3.7e-01
1.5e+00
—
2.1e+00
6.9e-01
3.5e-01
cases:11.61%
controls:10.14%
cases:7.09%
controls:5.01%
cases:2.81%
controls:0.66%
—
—
cases:6.02%
controls:0.77%
cases:9.17%
controls:4.80%
cases:19.25%
controls:14.37%
103
898
784
7959
63
445
826
8438
25
59
864
8824
—
53
68
827
8798
78
416
773
8248
143
1094
600
6517
mirtazapine; oral
N06AX11 [21604740]
N06AX11 [21604740]
7.0e-01
5.9e-01
9.9e-01
—
1.0e+00
7.2e-01
5.8e-01
cases:9.58%
controls:5.00%
cases:4.84%
controls:2.75%
cases:2.02%
controls:0.77%
—
—
cases:1.82%
controls:0.65%
cases:5.76%
controls:2.90%
cases:10.90%
controls:6.39%
85
443
802
8414
43
244
846
8639
18
68
871
8815
—
16
58
864
8808
49
251
802
8413
81
486
662
7125
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
1.7e-01
2.6e-01
4.2e-01
2.6e+00
9.4e-01
6.3e-01
4.7e-01
cases:12.06%
controls:10.34%
cases:8.55%
controls:6.71%
cases:2.47%
controls:1.63%
cases:1.01%
controls:0.08%
cases:4.77%
controls:1.92%
cases:12.34%
controls:6.98%
cases:20.46%
controls:13.90%
107
916
780
7941
76
596
813
8287
22
145
867
8738
9
7
880
8876
42
170
838
8696
105
605
746
8059
152
1058
591
6553
Cervical spine CT examination
NA1AD [2001306982]
NA1AD [2001306982]
1.4e+00
1.6e+00
—
1.0e+50
—
—
1.5e+00
cases:1.13%
controls:0.27%
cases:0.90%
controls:0.18%
—
—
cases:0.56%
controls:0.00%
—
—
—
—
cases:1.88%
controls:0.42%
10
24
877
8833
8
16
881
8867
—
5
0
884
8883
—
—
14
32
729
7579
Erysipelas
A46 [45561706]
A46 [45561706]
8.7e-01
1.4e+00
—
—
—
1.4e+00
8.2e-01
cases:3.27%
controls:1.40%
cases:2.02%
controls:0.48%
—
—
—
—
—
—
cases:1.88%
controls:0.47%
cases:4.58%
controls:2.06%
29
124
858
8733
18
43
871
8840
—
—
—
16
41
835
8623
34
157
709
7454
Benign tumor of the meninges on the outer surface of the cerebrum
D32.00 [2000501307]
D32.00 [2000501307]
2.3e+00
—
—
—
—
—
2.2e+00
cases:0.90%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.11%
8
8
879
8849
—
—
—
—
—
7
8
736
7603
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
6.7e-02
1.9e-01
1.1e+00
—
3.4e+00
1.1e+00
3.7e-01
cases:7.89%
controls:7.42%
cases:3.94%
controls:3.29%
cases:1.12%
controls:0.37%
—
—
cases:8.98%
controls:0.33%
cases:7.29%
controls:2.61%
cases:12.79%
controls:9.24%
70
657
817
8200
35
292
854
8591
10
33
879
8850
—
79
29
801
8837
62
226
789
8438
95
703
648
6908
Rehabilitation Hospital
283X00000X [38004285]
283X00000X [38004285]
—
—
—
—
—
2.7e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.06%
cases:1.48%
controls:0.25%
—
—
—
—
—
7
5
844
8659
11
19
732
7592
Alcohol intoxication UNS
F10.09 [2000501676]
F10.09 [2000501676]
2.2e+00
—
—
—
—
2.2e+00
1.7e+00
cases:1.47%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.10%
cases:0.94%
controls:0.17%
13
15
874
8842
—
—
—
—
8
9
843
8655
7
13
736
7598
Urine methamphetamine measurement
313579004 [4198724]
313579004 [4198724]
2.2e+00
—
—
1.0e+50
—
—
2.1e+00
cases:1.01%
controls:0.11%
—
—
—
—
cases:0.79%
controls:0.00%
—
—
—
—
cases:1.21%
controls:0.14%
9
10
878
8847
—
—
7
0
882
8883
—
—
9
11
734
7600
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
3.1e-01
3.0e-01
1.0e+00
—
2.1e+00
5.2e-01
3.6e-01
cases:40.25%
controls:33.09%
cases:18.56%
controls:14.47%
cases:5.40%
controls:2.03%
—
—
cases:13.75%
controls:1.94%
cases:21.62%
controls:14.09%
cases:42.40%
controls:33.91%
357
2931
530
5926
165
1285
724
7598
48
180
841
8703
—
121
172
759
8694
184
1221
667
7443
315
2581
428
5030
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
3.1e-01
3.0e-01
1.0e+00
—
2.1e+00
5.2e-01
3.6e-01
cases:40.25%
controls:33.09%
cases:18.56%
controls:14.47%
cases:5.40%
controls:2.03%
—
—
cases:13.75%
controls:1.94%
cases:21.62%
controls:14.09%
cases:42.40%
controls:33.91%
357
2931
530
5926
165
1285
724
7598
48
180
841
8703
—
121
172
759
8694
184
1221
667
7443
315
2581
428
5030
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
8.6e-01
5.4e-01
—
—
2.5e+00
6.3e-01
9.2e-01
cases:3.95%
controls:1.70%
cases:1.35%
controls:0.79%
—
—
—
—
cases:0.68%
controls:0.06%
cases:1.29%
controls:0.69%
cases:4.98%
controls:2.05%
35
151
852
8706
12
70
877
8813
—
—
6
5
874
8861
11
60
840
8604
37
156
706
7455
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
8.1e-01
9.4e-01
—
1.0e+50
—
1.7e+00
8.0e-01
cases:4.06%
controls:1.84%
cases:1.91%
controls:0.75%
—
—
cases:0.56%
controls:0.00%
—
—
cases:3.41%
controls:0.67%
cases:5.25%
controls:2.42%
36
163
851
8694
17
67
872
8816
—
5
0
884
8883
—
29
58
822
8606
39
184
704
7427
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
F32.10 [2000501980]
1.0e+00
1.1e+00
—
—
—
1.9e+00
1.3e+00
cases:2.59%
controls:0.97%
cases:0.90%
controls:0.29%
—
—
—
—
—
—
cases:1.65%
controls:0.25%
cases:3.10%
controls:0.84%
23
86
864
8771
8
26
881
8857
—
—
—
14
22
837
8642
23
64
720
7547
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
9.1e-01
1.0e+00
6.1e-01
—
5.8e-01
1.2e+00
1.0e+00
cases:7.33%
controls:3.09%
cases:5.40%
controls:2.02%
cases:1.24%
controls:0.68%
—
—
cases:1.02%
controls:0.58%
cases:7.05%
controls:2.17%
cases:9.96%
controls:3.73%
65
274
822
8583
48
179
841
8704
11
60
878
8823
—
9
51
871
8815
60
188
791
8476
74
284
669
7327
Major dressing of wound of skin of upper limb
QCB10 [2001309904]
QCB10 [2001309904]
—
2.3e+00
1.0e+50
1.0e+50
1.0e+50
—
1.9e+00
—
—
cases:0.79%
controls:0.08%
cases:0.79%
controls:0.00%
cases:1.12%
controls:0.00%
cases:2.84%
controls:0.00%
—
—
cases:0.94%
controls:0.14%
—
7
7
882
8876
7
0
882
8883
10
0
879
8883
25
0
855
8866
—
7
11
736
7600
Epilepsy
G40 [45595935]
G40 [45595935]
9.9e-01
—
—
—
—
2.5e+00
1.6e+00
cases:0.79%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.06%
cases:1.21%
controls:0.24%
7
26
880
8831
—
—
—
—
6
5
845
8659
9
18
734
7593
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
1.3e-01
4.2e-01
—
—
2.3e+00
1.1e+00
7.5e-01
cases:4.17%
controls:3.67%
cases:1.57%
controls:1.04%
—
—
—
—
cases:1.48%
controls:0.15%
cases:2.70%
controls:0.95%
cases:7.13%
controls:3.49%
37
325
850
8532
14
92
875
8791
—
—
13
13
867
8853
23
82
828
8582
53
266
690
7345
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
3.2e-01
7.9e-01
1.1e+00
—
2.0e+00
7.4e-01
5.7e-01
cases:7.89%
controls:5.84%
cases:5.51%
controls:2.59%
cases:1.12%
controls:0.37%
—
—
cases:2.39%
controls:0.33%
cases:5.41%
controls:2.64%
cases:13.46%
controls:8.11%
70
517
817
8340
49
230
840
8653
10
33
879
8850
—
21
29
859
8837
46
229
805
8435
100
617
643
6994
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
3.5e-01
5.4e-01
1.0e+00
—
1.8e+00
7.2e-01
3.5e-01
cases:9.24%
controls:6.72%
cases:6.07%
controls:3.64%
cases:1.69%
controls:0.61%
—
—
cases:4.77%
controls:0.81%
cases:7.17%
controls:3.62%
cases:13.06%
controls:9.58%
82
595
805
8262
54
323
835
8560
15
54
874
8829
—
42
72
838
8794
61
314
790
8350
97
729
646
6882
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
F31.30 [2000501976]
8.7e-01
—
—
—
—
2.3e+00
1.8e+00
cases:0.56%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.09%
cases:1.21%
controls:0.21%
5
21
882
8836
—
—
—
—
8
8
843
8656
9
16
734
7595
Delusional disorder
F22.0 [45581451]
F22.0 [45581451]
2.0e+00
—
—
—
—
—
2.0e+00
cases:0.68%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.21%
controls:0.16%
6
8
881
8849
—
—
—
—
—
9
12
734
7599
Chronic viral hepatitis C
B18.2 [45590846]
B18.2 [45590846]
1.9e+00
—
—
—
—
—
2.2e+00
cases:0.79%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.11%
7
11
880
8846
—
—
—
—
—
7
8
736
7603
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
3.4e-01
4.1e-01
1.9e-01
2.2e+00
6.1e-01
5.6e-01
5.6e-01
cases:18.49%
controls:13.93%
cases:11.36%
controls:7.84%
cases:2.14%
controls:1.77%
cases:0.67%
controls:0.08%
cases:3.18%
controls:1.75%
cases:13.16%
controls:7.95%
cases:24.90%
controls:15.94%
164
1234
723
7623
101
696
788
8187
19
157
870
8726
6
7
883
8876
28
155
852
8711
112
689
739
7975
185
1213
558
6398
Oxygen saturation in Venous blood
2711-0 [3024928]
2711-0 [3024928]
1.9e+00
2.2e+00
—
—
—
—
1.0e+00
cases:0.79%
controls:0.12%
cases:0.67%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.21%
controls:0.45%
7
11
880
8846
6
7
883
8876
—
—
—
—
9
34
734
7577
Neurology
13 [38004458]
13 [38004458]
5.9e-01
7.6e-01
1.2e+00
—
7.4e-01
9.5e-01
5.4e-01
cases:14.09%
controls:8.37%
cases:7.42%
controls:3.62%
cases:2.47%
controls:0.78%
—
—
cases:1.48%
controls:0.71%
cases:8.93%
controls:3.65%
cases:14.40%
controls:8.96%
125
741
762
8116
66
322
823
8561
22
69
867
8814
—
13
63
867
8803
76
316
775
8348
107
682
636
6929
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
6.8e-01
6.4e-01
1.3e+00
-1.0e+50
1.0e+00
8.3e-01
5.6e-01
cases:7.55%
controls:3.97%
cases:4.50%
controls:2.43%
cases:1.57%
controls:0.45%
cases:0.00%
controls:0.06%
cases:1.36%
controls:0.51%
cases:5.64%
controls:2.54%
cases:10.50%
controls:6.27%
67
352
820
8505
40
216
849
8667
14
40
875
8843
0
5
889
8878
12
45
868
8821
48
220
803
8444
78
477
665
7134
Acute alcohol abuse
P16 [2002000812]
P16 [2002000812]
2.3e+00
—
—
—
—
—
1.6e+00
cases:0.90%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.21%
8
8
879
8849
—
—
—
—
—
8
16
735
7595
Anxiety disorder, unspecified
F41.9 [45542849]
F41.9 [45542849]
1.0e+00
1.7e+00
—
—
—
1.2e+00
7.3e-01
cases:2.82%
controls:1.00%
cases:1.57%
controls:0.28%
—
—
—
—
—
—
cases:1.53%
controls:0.48%
cases:2.83%
controls:1.38%
25
89
862
8768
14
25
875
8858
—
—
—
13
42
838
8622
21
105
722
7506
Alcohol dependence continuous use
F10.25 [2000501682]
F10.25 [2000501682]
2.1e+00
—
—
—
—
—
1.8e+00
cases:1.35%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:1.21%
controls:0.20%
12
15
875
8842
—
—
—
—
—
9
15
734
7596
Other psychiatric treatment contact
IGY99 [2001304323]
IGY99 [2001304323]
1.9e+00
—
—
—
—
2.0e+00
1.1e+00
cases:0.79%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.13%
cases:0.81%
controls:0.26%
7
11
880
8846
—
—
—
—
8
11
843
8653
6
20
737
7591
lamotrigine; oral
N03AX09 [21604431]
N03AX09 [21604431]
9.9e-01
1.1e+00
—
—
—
1.5e+00
1.4e+00
cases:1.80%
controls:0.68%
cases:1.12%
controls:0.38%
—
—
—
—
—
—
cases:1.76%
controls:0.39%
cases:2.69%
controls:0.71%
16
60
871
8797
10
34
879
8849
—
—
—
15
34
836
8630
20
54
723
7557
Pain general/multiple sites
A01 [2002000142]
A01 [2002000142]
1.4e+00
1.3e+00
—
—
—
1.5e+00
9.7e-01
cases:1.92%
controls:0.46%
cases:0.90%
controls:0.26%
—
—
—
—
—
—
cases:1.18%
controls:0.28%
cases:2.69%
controls:1.04%
17
41
870
8816
8
23
881
8860
—
—
—
10
24
841
8640
20
79
723
7532
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
3.6e-01
8.1e-01
1.5e+00
—
1.6e+00
6.0e-01
3.6e-01
cases:5.64%
controls:4.01%
cases:4.05%
controls:1.85%
cases:1.24%
controls:0.28%
—
—
cases:1.59%
controls:0.34%
cases:4.11%
controls:2.30%
cases:8.48%
controls:6.04%
50
355
837
8502
36
164
853
8719
11
25
878
8858
—
14
30
866
8836
35
199
816
8465
63
460
680
7151
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
7.6e-01
5.1e-01
—
—
—
1.9e+00
1.2e+00
cases:3.61%
controls:1.72%
cases:1.12%
controls:0.68%
—
—
—
—
—
—
cases:4.00%
controls:0.62%
cases:5.38%
controls:1.73%
32
152
855
8705
10
60
879
8823
—
—
—
34
54
817
8610
40
132
703
7479
Epilepsy, unspecified
G40.9 [45562083]
G40.9 [45562083]
7.2e-01
1.3e+00
—
1.0e+50
—
2.2e+00
1.6e+00
cases:1.01%
controls:0.50%
cases:0.67%
controls:0.19%
—
—
cases:0.56%
controls:0.00%
—
—
cases:1.29%
controls:0.15%
cases:1.75%
controls:0.34%
9
44
878
8813
6
17
883
8866
—
5
0
884
8883
—
11
13
840
8651
13
26
730
7585
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
8.2e-01
1.3e+00
2.1e+00
1.0e+50
—
1.7e+00
2.2e-01
cases:3.16%
controls:1.41%
cases:2.25%
controls:0.62%
cases:0.56%
controls:0.07%
cases:1.91%
controls:0.00%
—
—
cases:2.35%
controls:0.45%
cases:2.83%
controls:2.29%
28
125
859
8732
20
55
869
8828
5
6
884
8877
17
0
872
8883
—
20
39
831
8625
21
174
722
7437
Ethanol [Moles/volume] in Serum or Plasma
14719-9 [3020191]
14719-9 [3020191]
2.0e+00
—
—
1.0e+50
—
—
1.8e+00
cases:1.01%
controls:0.14%
—
—
—
—
cases:1.01%
controls:0.00%
—
—
—
—
cases:1.08%
controls:0.18%
9
12
878
8845
—
—
9
0
880
8883
—
—
8
14
735
7597
Internal Medicine
11 [38004456]
11 [38004456]
4.1e-01
3.3e-01
1.2e+00
—
7.1e-01
7.7e-01
6.7e-01
cases:27.62%
controls:20.14%
cases:12.04%
controls:8.98%
cases:4.27%
controls:1.31%
—
—
cases:3.41%
controls:1.70%
cases:15.16%
controls:7.64%
cases:30.42%
controls:18.26%
245
1784
642
7073
107
798
782
8085
38
116
851
8767
—
30
151
850
8715
129
662
722
8002
226
1390
517
6221
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
7.8e-01
8.0e-01
9.2e-01
—
4.3e-01
1.1e+00
1.1e+00
cases:5.64%
controls:2.68%
cases:3.26%
controls:1.50%
cases:1.01%
controls:0.41%
—
—
cases:0.80%
controls:0.52%
cases:4.58%
controls:1.54%
cases:7.40%
controls:2.64%
50
237
837
8620
29
133
860
8750
9
36
880
8847
—
7
46
873
8820
39
133
812
8531
55
201
688
7410
Bipolar affective disorder, unspecified
F31.9 [45571758]
F31.9 [45571758]
1.1e+00
—
-1.0e+50
—
—
2.2e+00
1.5e+00
cases:0.90%
controls:0.32%
—
—
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.29%
controls:0.14%
cases:1.62%
controls:0.37%
8
28
879
8829
—
0
5
889
8878
—
—
11
12
840
8652
12
28
731
7583
Accelerated psychiatric treatment contact
IGY01 [2001304321]
IGY01 [2001304321]
—
1.8e+00
—
—
—
2.1e+00
1.6e+00
—
—
cases:0.67%
controls:0.11%
—
—
—
—
—
—
cases:1.18%
controls:0.15%
cases:1.35%
controls:0.28%
—
6
10
883
8873
—
—
—
10
13
841
8651
10
21
733
7590
Recurrent depression, mild episode without somatic syndrome
F33.00 [2000501982]
F33.00 [2000501982]
2.0e+00
—
—
—
—
—
1.7e+00
cases:0.79%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.20%
7
10
880
8847
—
—
—
—
—
8
15
735
7596
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
2.1e-01
4.3e-01
—
—
3.6e+00
6.4e-01
1.3e-01
cases:5.30%
controls:4.34%
cases:2.25%
controls:1.47%
—
—
—
—
cases:3.98%
controls:0.11%
cases:2.35%
controls:1.26%
cases:5.79%
controls:5.10%
47
384
840
8473
20
131
869
8752
—
—
35
10
845
8856
20
109
831
8555
43
388
700
7223
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
1.3e+00
1.0e+00
—
1.0e+50
—
1.3e+00
4.0e-01
cases:3.27%
controls:0.87%
cases:1.69%
controls:0.63%
—
—
cases:0.56%
controls:0.00%
—
—
cases:2.12%
controls:0.61%
cases:3.23%
controls:2.19%
29
77
858
8780
15
56
874
8827
—
5
0
884
8883
—
18
53
833
8611
24
167
719
7444
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
ZXE13 [2001311404]
1.5e+00
—
—
—
—
2.1e+00
1.2e+00
cases:1.47%
controls:0.34%
—
—
—
—
—
—
—
—
cases:1.29%
controls:0.16%
cases:0.67%
controls:0.21%
13
30
874
8827
—
—
—
—
11
14
840
8650
5
16
738
7595
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
3.5e-01
6.3e-01
—
1.0e+50
2.6e+00
9.8e-01
4.6e-01
cases:3.27%
controls:2.33%
cases:1.35%
controls:0.72%
—
—
cases:1.12%
controls:0.00%
cases:1.02%
controls:0.08%
cases:1.88%
controls:0.72%
cases:3.90%
controls:2.51%
29
206
858
8651
12
64
877
8819
—
10
0
879
8883
9
7
871
8859
16
62
835
8602
29
191
714
7420
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
Z76.9 [45609967]
1.1e+00
1.5e+00
—
—
—
8.6e-01
9.8e-01
cases:1.92%
controls:0.67%
cases:1.12%
controls:0.26%
—
—
—
—
—
—
cases:0.71%
controls:0.30%
cases:2.96%
controls:1.13%
17
59
870
8798
10
23
879
8860
—
—
—
6
26
845
8638
22
86
721
7525
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
QDB10 [2001309970]
8.9e-01
1.1e+00
—
1.0e+50
—
3.5e+00
1.0e+00
cases:1.01%
controls:0.42%
cases:0.56%
controls:0.19%
—
—
cases:1.01%
controls:0.00%
—
—
cases:3.41%
controls:0.10%
cases:1.21%
controls:0.45%
9
37
878
8820
5
17
884
8866
—
9
0
880
8883
—
29
9
822
8655
9
34
734
7577
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
1.3e+00
9.6e-01
—
—
1.6e+00
1.3e+00
4.5e-01
cases:3.95%
controls:1.13%
cases:2.02%
controls:0.79%
—
—
—
—
cases:0.57%
controls:0.11%
cases:2.70%
controls:0.77%
cases:4.04%
controls:2.61%
35
100
852
8757
18
70
871
8813
—
—
5
10
875
8856
23
67
828
8597
30
199
713
7412
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
-4.8e-01
6.6e-01
—
—
2.2e+00
1.3e+00
6.0e-01
cases:0.68%
controls:1.08%
cases:1.24%
controls:0.64%
—
—
—
—
cases:2.16%
controls:0.25%
cases:2.70%
controls:0.75%
cases:3.63%
controls:2.02%
6
96
881
8761
11
57
878
8826
—
—
19
22
861
8844
23
65
828
8599
27
154
716
7457
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
1.3e+00
9.4e-01
—
—
1.6e+00
1.2e+00
4.5e-01
cases:3.95%
controls:1.11%
cases:2.02%
controls:0.80%
—
—
—
—
cases:0.57%
controls:0.11%
cases:2.59%
controls:0.78%
cases:4.17%
controls:2.71%
35
98
852
8759
18
71
871
8812
—
—
5
10
875
8856
22
68
829
8596
31
206
712
7405
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
6.5e-01
7.4e-01
1.9e+00
—
1.3e+00
6.9e-01
4.9e-01
cases:6.09%
controls:3.27%
cases:3.26%
controls:1.58%
cases:1.01%
controls:0.15%
—
—
cases:0.68%
controls:0.18%
cases:2.82%
controls:1.43%
cases:4.98%
controls:3.10%
54
290
833
8567
29
140
860
8743
9
13
880
8870
—
6
16
874
8850
24
124
827
8540
37
236
706
7375
lithium; oral
N05AN01 [21604556]
N05AN01 [21604556]
9.8e-01
8.4e-01
—
—
—
1.6e+00
1.6e+00
cases:1.01%
controls:0.38%
cases:0.67%
controls:0.29%
—
—
—
—
—
—
cases:1.41%
controls:0.28%
cases:1.62%
controls:0.32%
9
34
878
8823
6
26
883
8857
—
—
—
12
24
839
8640
12
24
731
7587
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
8.2e-01
1.3e+00
2.1e+00
1.0e+50
—
1.2e+00
6.7e-01
cases:3.61%
controls:1.61%
cases:2.02%
controls:0.56%
cases:0.56%
controls:0.07%
cases:1.91%
controls:0.00%
—
—
cases:1.65%
controls:0.52%
cases:3.50%
controls:1.83%
32
143
855
8714
18
50
871
8833
5
6
884
8877
17
0
872
8883
—
14
45
837
8619
26
139
717
7472
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
8.4e-01
8.9e-01
8.4e-01
—
5.2e-01
8.1e-01
7.4e-01
cases:9.13%
controls:4.17%
cases:4.84%
controls:2.05%
cases:1.57%
controls:0.69%
—
—
cases:1.14%
controls:0.68%
cases:4.94%
controls:2.25%
cases:9.42%
controls:4.74%
81
369
806
8488
43
182
846
8701
14
61
875
8822
—
10
60
870
8806
42
195
809
8469
70
361
673
7250
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
3.5e-01
2.0e-01
3.8e-01
1.5e+00
7.3e-01
6.0e-01
6.1e-01
cases:94.70%
controls:92.64%
cases:83.24%
controls:80.20%
cases:49.61%
controls:40.18%
cases:8.77%
controls:2.06%
cases:57.95%
controls:39.80%
cases:88.01%
controls:80.19%
cases:96.37%
controls:93.51%
840
8205
47
652
740
7124
149
1759
441
3569
448
5314
78
183
811
8700
510
3529
370
5337
749
6948
102
1716
716
7117
27
494
Fungus identified in Specimen by Culture
580-1 [3000494]
580-1 [3000494]
1.6e-01
-7.9e-04
—
—
2.5e+00
8.0e-02
7.6e-01
cases:2.14%
controls:1.83%
cases:0.67%
controls:0.68%
—
—
—
—
cases:0.80%
controls:0.07%
cases:0.59%
controls:0.54%
cases:4.17%
controls:2.00%
19
162
868
8695
6
60
883
8823
—
—
7
6
873
8860
5
47
846
8617
31
152
712
7459
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
3.8e-01
3.0e-01
8.8e-01
—
1.1e+00
6.4e-01
5.7e-01
cases:10.03%
controls:7.09%
cases:7.65%
controls:5.80%
cases:2.81%
controls:1.18%
—
—
cases:3.86%
controls:1.30%
cases:10.93%
controls:6.05%
cases:17.90%
controls:11.00%
89
628
798
8229
68
515
821
8368
25
105
864
8778
—
34
115
846
8751
93
524
758
8140
133
837
610
6774
Assessment of need for psychiatric treatment
IAA01 [2001304011]
IAA01 [2001304011]
—
—
—
—
—
1.9e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.13%
cases:2.02%
controls:0.54%
—
—
—
—
—
7
11
844
8653
15
41
728
7570
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
3.5e-01
5.0e-01
2.3e+00
—
—
7.7e-01
8.9e-01
cases:3.16%
controls:2.24%
cases:1.46%
controls:0.89%
cases:0.67%
controls:0.07%
—
—
—
—
cases:1.41%
controls:0.66%
cases:5.52%
controls:2.35%
28
198
859
8659
13
79
876
8804
6
6
883
8877
—
—
12
57
839
8607
41
179
702
7432
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
4.0e-01
2.6e-01
1.2e+00
—
2.0e+00
6.9e-01
5.4e-01
cases:10.03%
controls:6.98%
cases:3.26%
controls:2.53%
cases:0.67%
controls:0.21%
—
—
cases:1.02%
controls:0.15%
cases:4.58%
controls:2.34%
cases:11.71%
controls:7.15%
89
618
798
8239
29
225
860
8658
6
19
883
8864
—
9
13
871
8853
39
203
812
8461
87
544
656
7067
Hypothyroidism, unspecified
E03.9 [45537945]
E03.9 [45537945]
3.5e-01
5.8e-01
2.1e+00
—
2.3e+00
6.6e-01
8.6e-01
cases:1.92%
controls:1.35%
cases:1.12%
controls:0.63%
cases:0.56%
controls:0.07%
—
—
cases:0.80%
controls:0.08%
cases:1.18%
controls:0.61%
cases:3.50%
controls:1.51%
17
120
870
8737
10
56
879
8827
5
6
884
8877
—
7
7
873
8859
10
53
841
8611
26
115
717
7496
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
4.2e-01
4.6e-01
1.3e+00
—
2.1e+00
1.1e+00
4.6e-01
cases:3.61%
controls:2.40%
cases:1.91%
controls:1.22%
cases:0.56%
controls:0.16%
—
—
cases:1.02%
controls:0.12%
cases:3.53%
controls:1.26%
cases:5.92%
controls:3.81%
32
213
855
8644
17
108
872
8775
5
14
884
8869
—
9
11
871
8855
30
109
821
8555
44
290
699
7321
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
5.8e-01
8.2e-01
1.1e+00
—
5.0e-01
1.3e+00
1.1e+00
cases:3.72%
controls:2.12%
cases:3.04%
controls:1.36%
cases:1.12%
controls:0.36%
—
—
cases:0.80%
controls:0.48%
cases:4.47%
controls:1.29%
cases:7.13%
controls:2.58%
33
188
854
8669
27
121
862
8762
10
32
879
8851
—
7
43
873
8823
38
112
813
8552
53
196
690
7415
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
8.5e-01
7.6e-01
—
—
-1.0e+50
1.4e+00
8.9e-01
cases:3.27%
controls:1.42%
cases:1.12%
controls:0.53%
—
—
—
—
cases:0.00%
controls:0.07%
cases:2.00%
controls:0.50%
cases:3.77%
controls:1.58%
29
126
858
8731
10
47
879
8836
—
—
0
6
880
8860
17
43
834
8621
28
120
715
7491
Psychiatric monitoring contact
IGY02 [2001304322]
IGY02 [2001304322]
1.4e+00
—
—
—
—
1.8e+00
1.3e+00
cases:0.79%
controls:0.19%
—
—
—
—
—
—
—
—
cases:1.18%
controls:0.20%
cases:1.62%
controls:0.43%
7
17
880
8840
—
—
—
—
10
17
841
8647
12
33
731
7578
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
6.6e-02
6.0e-01
—
—
3.1e+00
9.2e-01
1.5e-01
cases:1.58%
controls:1.48%
cases:1.12%
controls:0.62%
—
—
—
—
cases:1.48%
controls:0.07%
cases:1.41%
controls:0.57%
cases:2.56%
controls:2.21%
14
131
873
8726
10
55
879
8828
—
—
13
6
867
8860
12
49
839
8615
19
168
724
7443
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
95941-1 [36031861]
8.2e-01
1.8e+00
—
—
—
1.0e+00
1.3e+00
cases:0.56%
controls:0.25%
cases:1.12%
controls:0.18%
—
—
—
—
—
—
cases:1.18%
controls:0.43%
cases:3.50%
controls:1.02%
5
22
882
8835
10
16
879
8867
—
—
—
10
37
841
8627
26
78
717
7533
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
5.8e-02
5.0e-01
7.3e-01
—
1.5e+00
6.6e-01
4.3e-01
cases:13.53%
controls:12.86%
cases:9.45%
controls:5.98%
cases:2.25%
controls:1.09%
—
—
cases:3.64%
controls:0.83%
cases:11.05%
controls:6.04%
cases:22.34%
controls:15.71%
120
1139
767
7718
84
531
805
8352
20
97
869
8786
—
32
74
848
8792
94
523
757
8141
166
1196
577
6415
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
4.8e-01
2.6e-01
8.9e-01
—
1.3e+00
6.7e-01
6.8e-01
cases:8.68%
controls:5.58%
cases:4.72%
controls:3.68%
cases:1.46%
controls:0.61%
—
—
cases:2.50%
controls:0.72%
cases:7.29%
controls:3.88%
cases:14.00%
controls:7.61%
77
494
810
8363
42
327
847
8556
13
54
876
8829
—
22
64
858
8802
62
336
789
8328
104
579
639
7032
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
N05AB03 [21604502]
1.4e+00
1.6e+00
—
—
—
1.6e+00
1.7e+00
cases:1.35%
controls:0.35%
cases:0.67%
controls:0.14%
—
—
—
—
—
—
cases:0.71%
controls:0.15%
cases:1.08%
controls:0.20%
12
31
875
8826
6
12
883
8871
—
—
—
6
13
845
8651
8
15
735
7596
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
48065-7 [3051714]
3.1e-01
3.3e-01
1.3e+00
—
2.0e+00
9.7e-01
4.9e-01
cases:4.06%
controls:3.01%
cases:1.46%
controls:1.06%
cases:0.56%
controls:0.16%
—
—
cases:0.68%
controls:0.09%
cases:2.82%
controls:1.08%
cases:7.00%
controls:4.41%
36
267
851
8590
13
94
876
8789
5
14
884
8869
—
6
8
874
8858
24
94
827
8570
52
336
691
7275
Hand and fingers X-ray examination
ND2AA [2001307607]
ND2AA [2001307607]
1.1e+00
—
—
—
—
1.9e+00
7.7e-01
cases:2.03%
controls:0.70%
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.13%
cases:2.02%
controls:0.95%
18
62
869
8795
—
—
—
—
7
11
844
8653
15
72
728
7539
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
3.6e-01
3.6e-01
4.8e-01
—
1.2e+00
1.2e+00
5.1e-01
cases:5.52%
controls:3.93%
cases:3.49%
controls:2.45%
cases:1.12%
controls:0.70%
—
—
cases:2.27%
controls:0.68%
cases:8.58%
controls:2.77%
cases:11.04%
controls:6.91%
49
348
838
8509
31
218
858
8665
10
62
879
8821
—
20
60
860
8806
73
240
778
8424
82
526
661
7085
risperidone; oral, parenteral
N05AX08 [21604559]
N05AX08 [21604559]
1.1e+00
9.2e-01
—
—
—
1.0e+00
8.3e-01
cases:2.25%
controls:0.77%
cases:1.46%
controls:0.59%
—
—
—
—
—
—
cases:1.76%
controls:0.65%
cases:3.10%
controls:1.38%
20
68
867
8789
13
52
876
8831
—
—
—
15
56
836
8608
23
105
720
7506
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
12286-1 [3011288]
7.2e-01
7.4e-01
—
—
—
1.5e+00
1.4e+00
cases:1.35%
controls:0.67%
cases:0.56%
controls:0.27%
—
—
—
—
—
—
cases:1.06%
controls:0.24%
cases:3.63%
controls:0.93%
12
59
875
8798
5
24
884
8859
—
—
—
9
21
842
8643
27
71
716
7540
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
1.4e-01
1.4e-01
1.5e+00
—
1.3e+00
4.9e-01
4.4e-02
cases:6.54%
controls:5.72%
cases:3.26%
controls:2.85%
cases:1.46%
controls:0.32%
—
—
cases:1.25%
controls:0.35%
cases:4.35%
controls:2.71%
cases:9.29%
controls:8.92%
58
507
829
8350
29
253
860
8630
13
28
876
8855
—
11
31
869
8835
37
235
814
8429
69
679
674
6932
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
SPAT1149 [2001700250]
1.2e-01
—
—
—
2.8e+00
1.2e+00
7.7e-01
cases:1.35%
controls:1.20%
—
—
—
—
—
—
cases:1.48%
controls:0.09%
cases:1.18%
controls:0.37%
cases:2.69%
controls:1.26%
12
106
875
8751
—
—
—
13
8
867
8858
10
32
841
8632
20
96
723
7515
Profession-specific psychiatric evaluation
IBZ01 [2001304075]
IBZ01 [2001304075]
2.7e+00
—
—
—
—
—
1.1e+00
cases:1.01%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.32%
9
6
878
8851
—
—
—
—
—
7
24
736
7587
Ankle symptom/complaint
L16 [2002000640]
L16 [2002000640]
4.7e-01
1.8e+00
—
—
-1.0e+50
1.1e+00
9.2e-01
cases:1.80%
controls:1.14%
cases:1.12%
controls:0.19%
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.82%
controls:0.27%
cases:2.56%
controls:1.04%
16
101
871
8756
10
17
879
8866
—
—
0
5
880
8861
7
23
844
8641
19
79
724
7532
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
1.7e-01
6.7e-01
—
1.0e+50
2.7e+00
7.0e-01
1.3e-01
cases:3.95%
controls:3.35%
cases:2.02%
controls:1.05%
—
—
cases:1.12%
controls:0.00%
cases:1.14%
controls:0.08%
cases:2.00%
controls:1.00%
cases:4.58%
controls:4.06%
35
297
852
8560
18
93
871
8790
—
10
0
879
8883
10
7
870
8859
17
87
834
8577
34
309
709
7302
dexpanthenol
D03AX03 [21601991]
D03AX03 [21601991]
—
—
—
—
1.0e+50
—
2.7e+00
—
—
—
—
—
—
—
—
cases:1.59%
controls:0.00%
—
—
cases:0.94%
controls:0.07%
—
—
—
—
14
0
866
8866
—
7
5
736
7606
Hospital inpatient
ZY000 [2001311598]
ZY000 [2001311598]
2.6e+00
—
—
—
—
—
—
cases:1.24%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
11
8
876
8849
—
—
—
—
—
—
levetiracetam; oral, parenteral
N03AX14 [21604436]
N03AX14 [21604436]
1.4e+00
1.1e+00
—
—
—
1.2e+00
1.2e+00
cases:1.24%
controls:0.32%
cases:1.12%
controls:0.36%
—
—
—
—
—
—
cases:1.06%
controls:0.33%
cases:1.62%
controls:0.49%
11
28
876
8829
10
32
879
8851
—
—
—
9
29
842
8635
12
37
731
7574
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
3.9e-01
7.0e-01
1.9e+00
—
1.5e+00
1.1e+00
4.3e-01
cases:2.93%
controls:2.01%
cases:2.59%
controls:1.31%
cases:0.67%
controls:0.10%
—
—
cases:1.02%
controls:0.24%
cases:4.47%
controls:1.55%
cases:8.34%
controls:5.57%
26
178
861
8679
23
116
866
8767
6
9
883
8874
—
9
21
871
8845
38
134
813
8530
62
424
681
7187
Withdrawal symptoms caused by alcohol uncomplicated
F10.30 [2000501685]
F10.30 [2000501685]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.07%
—
—
—
—
—
—
6
5
737
7606
Systemic arterial pressure
364090009 [4238447]
364090009 [4238447]
1.4e+00
—
—
1.0e+50
—
2.5e+00
—
cases:0.68%
controls:0.17%
—
—
—
—
cases:1.01%
controls:0.00%
—
—
cases:0.71%
controls:0.06%
—
—
6
15
881
8842
—
—
9
0
880
8883
—
6
5
845
8659
—
Faecal incontinence
R15 [45573014]
R15 [45573014]
2.5e+00
—
—
—
—
—
—
cases:0.68%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
881
8852
—
—
—
—
—
—
Adaptation disorder UNS
F43.29 [2000502008]
F43.29 [2000502008]
—
—
—
—
—
2.5e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.07%
cases:0.81%
controls:0.18%
—
—
—
—
—
7
6
844
8658
6
14
737
7597
Ultrasound examination of lower leg veins
PH2AE [2001309451]
PH2AE [2001309451]
2.4e-01
5.8e-01
—
—
—
2.5e+00
5.5e-01
cases:1.24%
controls:0.98%
cases:0.56%
controls:0.32%
—
—
—
—
—
—
cases:1.76%
controls:0.15%
cases:1.88%
controls:1.09%
11
87
876
8770
5
28
884
8855
—
—
—
15
13
836
8651
14
83
729
7528
Vacuum treatment of wound
TQW11 [2001310078]
TQW11 [2001310078]
—
2.5e+00
—
1.0e+50
1.0e+50
—
—
—
—
cases:0.79%
controls:0.07%
—
—
cases:2.14%
controls:0.00%
cases:1.02%
controls:0.00%
—
—
—
—
—
7
6
882
8877
—
19
0
870
8883
9
0
871
8866
—
—
2-person team, doctor-nurse
ZXY51 [2001311525]
ZXY51 [2001311525]
2.5e+00
—
—
—
—
-1.0e+50
—
cases:0.79%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
7
6
880
8851
—
—
—
—
0
7
851
8657
—
Chief Physician, Head of Department or Deputy Chief Physician
ZXY01 [2001311511]
ZXY01 [2001311511]
2.5e+00
—
—
—
—
—
—
cases:0.79%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
7
6
880
8851
—
—
—
—
—
—
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
1.2e+00
8.8e-01
—
—
1.6e+00
1.2e+00
4.2e-01
cases:3.72%
controls:1.14%
cases:1.91%
controls:0.80%
—
—
—
—
cases:0.57%
controls:0.11%
cases:2.70%
controls:0.80%
cases:3.90%
controls:2.60%
33
101
854
8756
17
71
872
8812
—
—
5
10
875
8856
23
69
828
8595
29
198
714
7413
Post-traumatic stress disorder
F43.1 [45595909]
F43.1 [45595909]
1.3e+00
—
—
—
—
2.4e+00
1.2e+00
cases:0.56%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.09%
cases:1.35%
controls:0.39%
5
14
882
8843
—
—
—
—
9
8
842
8656
10
30
733
7581
Withdrawal symptoms caused by alcohol UNS
F10.39 [2000501687]
F10.39 [2000501687]
2.4e+00
—
—
—
—
—
1.9e+00
cases:0.90%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.12%
8
7
879
8850
—
—
—
—
—
6
9
737
7602
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
3.6e-01
4.7e-01
—
—
—
1.6e+00
8.5e-01
cases:2.82%
controls:1.98%
cases:0.90%
controls:0.56%
—
—
—
—
—
—
cases:2.12%
controls:0.45%
cases:4.04%
controls:1.76%
25
175
862
8682
8
50
881
8833
—
—
—
18
39
833
8625
30
134
713
7477
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
2.7e-01
5.3e-01
7.7e-01
—
1.3e+00
5.6e-01
2.7e-01
cases:15.56%
controls:12.31%
cases:9.56%
controls:5.84%
cases:1.69%
controls:0.79%
—
—
cases:2.73%
controls:0.76%
cases:9.52%
controls:5.67%
cases:23.01%
controls:18.58%
138
1090
749
7767
85
519
804
8364
15
70
874
8813
—
24
67
856
8799
81
491
770
8173
171
1414
572
6197
Open wound of scalp
S01.0 [45592468]
S01.0 [45592468]
1.1e+00
—
—
—
-1.0e+50
1.4e+00
1.2e+00
cases:1.58%
controls:0.52%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.71%
controls:0.17%
cases:2.83%
controls:0.83%
14
46
873
8811
—
—
—
0
5
880
8861
6
15
845
8649
21
63
722
7548
Split skin graft
ZZA00 [2001311610]
ZZA00 [2001311610]
1.6e+00
—
1.0e+50
1.0e+50
1.0e+50
—
2.3e+00
cases:0.68%
controls:0.14%
—
—
cases:0.67%
controls:0.00%
cases:8.55%
controls:0.00%
cases:6.93%
controls:0.00%
—
—
cases:1.48%
controls:0.14%
6
12
881
8845
—
6
0
883
8883
76
0
813
8883
61
0
819
8866
—
11
11
732
7600
Revision of wound of skin of upper limb
QCB05 [2001309903]
QCB05 [2001309903]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.07%
—
—
—
—
—
—
5
5
738
7606
Cell count panel - Pleural fluid
34561-1 [3045788]
34561-1 [3045788]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.07%
—
—
—
—
—
—
5
5
738
7606
Erythrocytes [#/volume] in Pleural fluid
26456-4 [3028308]
26456-4 [3028308]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.07%
—
—
—
—
—
—
5
5
738
7606
Treatment of eyes
SPAT1014 [2001700115]
SPAT1014 [2001700115]
—
—
—
—
—
-1.0e+50
2.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.67%
controls:0.07%
—
—
—
—
—
0
7
851
8657
5
5
738
7606
Scar conditions and fibrosis of skin
L90.5 [45543397]
L90.5 [45543397]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.07%
—
—
—
—
—
—
5
5
738
7606
Acute renal failure, unspecified
N17.9 [45567829]
N17.9 [45567829]
—
—
—
1.0e+50
—
2.3e+00
1.3e+00
—
—
—
—
—
—
cases:0.56%
controls:0.00%
—
—
cases:0.82%
controls:0.08%
cases:1.08%
controls:0.30%
—
—
—
5
0
884
8883
—
7
7
844
8657
8
23
735
7588
Mild depressive episode without somatic syndrome
F32.00 [2000501978]
F32.00 [2000501978]
1.1e+00
—
—
—
—
2.3e+00
8.3e-01
cases:0.90%
controls:0.32%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.07%
cases:0.81%
controls:0.35%
8
28
879
8829
—
—
—
—
6
6
845
8658
6
27
737
7584
Hepatitis A virus IgM Ab [Presence] in Serum
22314-9 [3013327]
22314-9 [3013327]
7.8e-01
—
—
—
—
2.3e+00
—
cases:0.56%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.06%
—
—
5
23
882
8834
—
—
—
—
5
5
846
8659
—
Skin texture symptom/complaint
S21 [2002000986]
S21 [2002000986]
5.2e-01
5.9e-01
—
—
2.3e+00
1.0e+00
6.6e-01
cases:1.92%
controls:1.15%
cases:1.01%
controls:0.56%
—
—
—
—
cases:0.68%
controls:0.07%
cases:1.53%
controls:0.57%
cases:3.36%
controls:1.76%
17
102
870
8755
9
50
880
8833
—
—
6
6
874
8860
13
49
838
8615
25
134
718
7477
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
X44 [45756400]
X44 [45756400]
2.3e+00
—
—
—
—
—
1.9e+00
cases:0.90%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.12%
8
8
879
8849
—
—
—
—
—
6
9
737
7602
fluoxetine; oral
N06AB03 [21604711]
N06AB03 [21604711]
7.4e-01
8.5e-01
1.5e+00
—
—
1.1e+00
1.2e+00
cases:2.82%
controls:1.37%
cases:1.46%
controls:0.63%
cases:0.67%
controls:0.16%
—
—
—
—
cases:1.88%
controls:0.62%
cases:2.69%
controls:0.85%
25
121
862
8736
13
56
876
8827
6
14
883
8869
—
—
16
54
835
8610
20
65
723
7546
Dorsalgia, unspecified
M54.9 [45538791]
M54.9 [45538791]
1.1e+00
7.0e-01
—
—
—
1.1e+00
1.2e+00
cases:2.48%
controls:0.85%
cases:0.67%
controls:0.34%
—
—
—
—
—
—
cases:0.71%
controls:0.24%
cases:3.36%
controls:1.05%
22
75
865
8782
6
30
883
8853
—
—
—
6
21
845
8643
25
80
718
7531
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
3.3e-01
5.5e-01
—
—
2.2e+00
6.1e-01
4.0e-01
cases:5.98%
controls:4.38%
cases:2.81%
controls:1.64%
—
—
—
—
cases:1.25%
controls:0.14%
cases:2.82%
controls:1.55%
cases:7.54%
controls:5.16%
53
388
834
8469
25
146
864
8737
—
—
11
12
869
8854
24
134
827
8530
56
393
687
7218
Bipolar affective disorder, current episode hypomanic
F31.0 [45542840]
F31.0 [45542840]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.12%
—
—
—
—
—
—
8
9
735
7602
Alcohol dependence periodic alcoholism
F10.26 [2000501683]
F10.26 [2000501683]
2.2e+00
—
—
—
—
2.1e+00
1.4e+00
cases:1.13%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.07%
cases:0.67%
controls:0.17%
10
11
877
8846
—
—
—
—
5
6
846
8658
5
13
738
7598
Diagnostic and symptom-mapping evaluation
IBA01 [2001304043]
IBA01 [2001304043]
2.2e+00
—
—
—
—
—
1.5e+00
cases:0.79%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.21%
7
8
880
8849
—
—
—
—
—
7
16
736
7595
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
3.4e-01
2.9e-01
7.8e-01
—
1.0e+00
6.4e-01
5.0e-01
cases:11.27%
controls:8.29%
cases:6.86%
controls:5.20%
cases:1.91%
controls:0.89%
—
—
cases:3.07%
controls:1.12%
cases:9.52%
controls:5.25%
cases:17.09%
controls:11.09%
100
734
787
8123
61
462
828
8421
17
79
872
8804
—
27
99
853
8767
81
455
770
8209
127
844
616
6767
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
3.5e-01
2.9e-01
7.8e-01
—
1.0e+00
6.3e-01
5.1e-01
cases:11.27%
controls:8.24%
cases:6.86%
controls:5.20%
cases:1.91%
controls:0.89%
—
—
cases:3.07%
controls:1.12%
cases:9.52%
controls:5.29%
cases:17.23%
controls:11.12%
100
730
787
8127
61
462
828
8421
17
79
872
8804
—
27
99
853
8767
81
458
770
8206
128
846
615
6765
Bipolar affective disorder, current episode severe depression without psychotic symptoms
F31.4 [45581456]
F31.4 [45581456]
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.08%
—
—
—
—
—
—
—
6
7
845
8657
—
duloxetine; oral
N06AX21 [21604749]
N06AX21 [21604749]
1.2e+00
5.1e-01
—
—
—
2.3e-01
9.7e-01
cases:3.72%
controls:1.15%
cases:1.12%
controls:0.68%
—
—
—
—
—
—
cases:0.94%
controls:0.75%
cases:3.77%
controls:1.46%
33
102
854
8755
10
60
879
8823
—
—
—
8
65
843
8599
28
111
715
7500
Psychological, Therapeutic counselling/listening
P58 [2002000852]
P58 [2002000852]
2.2e+00
—
—
—
—
—
—
cases:0.68%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
881
8850
—
—
—
—
—
—
Open wound of other parts of foot
S91.3 [45599027]
S91.3 [45599027]
—
-1.0e+50
—
—
—
—
2.1e+00
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.21%
controls:0.14%
—
0
6
889
8877
—
—
—
—
9
11
734
7600
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
4.7e-01
5.7e-01
—
—
—
9.4e-01
7.1e-01
cases:7.67%
controls:4.92%
cases:2.47%
controls:1.42%
—
—
—
—
—
—
cases:3.41%
controls:1.36%
cases:10.63%
controls:5.51%
68
436
819
8421
22
126
867
8757
—
—
—
29
118
822
8546
79
419
664
7192
Thrombin time
3243-3 [3036489]
3243-3 [3036489]
2.9e-01
1.0e+00
—
—
—
2.1e+00
1.2e+00
cases:0.90%
controls:0.68%
cases:0.67%
controls:0.25%
—
—
—
—
—
—
cases:0.94%
controls:0.12%
cases:1.48%
controls:0.46%
8
60
879
8797
6
22
883
8861
—
—
—
8
10
843
8654
11
35
732
7576
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
2.6e-01
2.0e-01
7.9e-01
—
9.8e-01
6.1e-01
5.1e-01
cases:10.60%
controls:8.38%
cases:6.41%
controls:5.32%
cases:1.91%
controls:0.88%
—
—
cases:2.95%
controls:1.13%
cases:9.52%
controls:5.39%
cases:17.36%
controls:11.22%
94
742
793
8115
57
473
832
8410
17
78
872
8805
—
26
100
854
8766
81
467
770
8197
129
854
614
6757
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
3.5e-01
2.8e-01
8.0e-01
—
9.9e-01
6.1e-01
5.0e-01
cases:11.27%
controls:8.24%
cases:6.75%
controls:5.18%
cases:1.91%
controls:0.87%
—
—
cases:2.95%
controls:1.12%
cases:9.28%
controls:5.27%
cases:17.09%
controls:11.09%
100
730
787
8127
60
460
829
8423
17
77
872
8806
—
26
99
854
8767
79
457
772
8207
127
844
616
6767
Paralysis/weakness
N18 [2002000729]
N18 [2002000729]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.12%
—
—
—
—
—
—
7
9
736
7602
Hand Surgery
40 [38004480]
40 [38004480]
5.1e-01
6.2e-01
—
—
—
1.2e+00
8.6e-01
cases:3.83%
controls:2.34%
cases:1.57%
controls:0.86%
—
—
—
—
—
—
cases:2.47%
controls:0.75%
cases:5.79%
controls:2.54%
34
207
853
8650
14
76
875
8807
—
—
—
21
65
830
8599
43
193
700
7418
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
OMOP4821986 [45756756]
7.3e-01
8.7e-01
—
—
2.1e+00
1.4e+00
1.2e+00
cases:1.47%
controls:0.71%
cases:0.56%
controls:0.24%
—
—
—
—
cases:0.80%
controls:0.10%
cases:0.94%
controls:0.23%
cases:1.48%
controls:0.47%
13
63
874
8794
5
21
884
8862
—
—
7
9
873
8857
8
20
843
8644
11
36
732
7575
Chronic ulcer skin
S97 [2002001061]
S97 [2002001061]
9.5e-01
1.1e+00
—
—
—
2.1e+00
4.5e-01
cases:1.13%
controls:0.44%
cases:0.67%
controls:0.23%
—
—
—
—
—
—
cases:1.53%
controls:0.20%
cases:1.21%
controls:0.78%
10
39
877
8818
6
20
883
8863
—
—
—
13
17
838
8647
9
59
734
7552
Bipolar affective disorder, current episode mixed
F31.6 [45571757]
F31.6 [45571757]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.11%
—
—
—
—
—
—
6
8
737
7603
Pelvis X-ray examination
NE1AA [2001307792]
NE1AA [2001307792]
7.0e-01
1.2e+00
—
—
—
2.0e+00
3.8e-01
cases:0.90%
controls:0.45%
cases:0.67%
controls:0.20%
—
—
—
—
—
—
cases:0.71%
controls:0.09%
cases:0.81%
controls:0.55%
8
40
879
8817
6
18
883
8865
—
—
—
6
8
845
8656
6
42
737
7569
Car occupant [any] injured in unspecified traffic accident
V49.9 [45566025]
V49.9 [45566025]
9.6e-01
—
—
—
—
2.0e+00
9.9e-01
cases:0.79%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.09%
cases:0.81%
controls:0.30%
7
27
880
8830
—
—
—
—
6
8
845
8656
6
23
737
7588
Other minor procedure on skin
TQW99 [2001310150]
TQW99 [2001310150]
—
—
—
—
—
2.0e+00
5.0e-01
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.09%
cases:0.67%
controls:0.41%
—
—
—
—
—
6
8
845
8656
5
31
738
7580
buspirone; oral
N05BE01 [21604601]
N05BE01 [21604601]
1.2e+00
—
—
—
—
2.0e+00
—
cases:0.79%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.09%
—
—
7
21
880
8836
—
—
—
—
6
8
845
8656
—
sulfadiazine and trimethoprim
J01EE02 [21602962]
J01EE02 [21602962]
4.9e-01
6.7e-01
-1.0e+50
—
2.0e+00
7.2e-01
3.8e-01
cases:4.85%
controls:3.04%
cases:1.57%
controls:0.81%
cases:0.00%
controls:0.11%
—
—
cases:0.68%
controls:0.09%
cases:1.65%
controls:0.81%
cases:3.10%
controls:2.14%
43
269
844
8588
14
72
875
8811
0
10
889
8873
—
6
8
874
8858
14
70
837
8594
23
163
720
7448
Laparotomy
JAH00 [2001304474]
JAH00 [2001304474]
2.0e+00
-1.0e+50
—
—
—
—
—
cases:0.68%
controls:0.09%
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
6
8
881
8849
0
5
889
8878
—
—
—
—
—
Contusion of knee
S80.0 [45569633]
S80.0 [45569633]
8.9e-01
—
—
—
—
2.0e+00
7.6e-01
cases:0.90%
controls:0.37%
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.13%
cases:1.75%
controls:0.83%
8
33
879
8824
—
—
—
—
8
11
843
8653
13
63
730
7548
Limited function/disability (L)
L28 [2002000647]
L28 [2002000647]
7.6e-01
5.8e-01
1.1e+00
—
1.6e+00
1.2e+00
5.0e-01
cases:2.82%
controls:1.34%
cases:1.24%
controls:0.70%
cases:0.56%
controls:0.19%
—
—
cases:0.57%
controls:0.11%
cases:2.70%
controls:0.80%
cases:4.17%
controls:2.56%
25
119
862
8738
11
62
878
8821
5
17
884
8866
—
5
10
875
8856
23
69
828
8595
31
195
712
7416
sertraline; oral
N06AB06 [21604714]
N06AB06 [21604714]
1.2e+00
8.5e-01
—
—
—
6.7e-01
8.1e-01
cases:4.17%
controls:1.32%
cases:1.69%
controls:0.73%
—
—
—
—
—
—
cases:1.41%
controls:0.73%
cases:3.77%
controls:1.71%
37
117
850
8740
15
65
874
8818
—
—
—
12
63
839
8601
28
130
715
7481
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
E11.8 [45561951]
3.8e-01
5.3e-01
2.0e+00
1.0e+50
2.1e+00
8.5e-01
3.7e-01
cases:1.47%
controls:1.00%
cases:0.90%
controls:0.53%
cases:0.90%
controls:0.12%
cases:0.56%
controls:0.00%
cases:0.57%
controls:0.07%
cases:1.53%
controls:0.66%
cases:2.42%
controls:1.68%
13
89
874
8768
8
47
881
8836
8
11
881
8872
5
0
884
8883
5
6
875
8860
13
57
838
8607
18
128
725
7483
Pain in limb
M79.6 [45587063]
M79.6 [45587063]
5.3e-01
1.3e-01
9.2e-01
—
1.4e+00
8.2e-01
6.3e-01
cases:7.55%
controls:4.57%
cases:2.36%
controls:2.07%
cases:0.67%
controls:0.27%
—
—
cases:0.91%
controls:0.23%
cases:4.11%
controls:1.85%
cases:12.79%
controls:7.23%
67
405
820
8452
21
184
868
8699
6
24
883
8859
—
8
20
872
8846
35
160
816
8504
95
550
648
7061
Neuralgia and neuritis, unspecified
M79.2 [45548502]
M79.2 [45548502]
1.5e+00
-1.0e+50
—
—
—
—
2.0e+00
cases:0.56%
controls:0.12%
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.13%
5
11
882
8846
0
5
889
8878
—
—
—
—
7
10
736
7601
venlafaxine; oral
N06AX16 [21604745]
N06AX16 [21604745]
5.8e-01
7.1e-01
1.1e+00
—
—
9.0e-01
1.1e+00
cases:3.27%
controls:1.85%
cases:2.25%
controls:1.11%
cases:0.79%
controls:0.26%
—
—
—
—
cases:2.82%
controls:1.17%
cases:6.19%
controls:2.21%
29
164
858
8693
20
99
869
8784
7
23
882
8860
—
—
24
101
827
8563
46
168
697
7443
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
L97 [45591659]
—
—
—
—
—
2.0e+00
9.5e-01
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.15%
cases:1.21%
controls:0.47%
—
—
—
—
—
9
13
842
8651
9
36
734
7575
Complicated migraine
G43.3 [45576576]
G43.3 [45576576]
2.0e+00
—
—
—
—
—
—
cases:0.79%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
7
10
880
8847
—
—
—
—
—
—
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
3.1e-01
2.4e-01
7.5e-01
—
9.4e-01
5.5e-01
4.4e-01
cases:11.39%
controls:8.61%
cases:6.86%
controls:5.46%
cases:1.91%
controls:0.91%
—
—
cases:2.95%
controls:1.17%
cases:9.28%
controls:5.59%
cases:16.96%
controls:11.60%
101
763
786
8094
61
485
828
8398
17
81
872
8802
—
26
104
854
8762
79
484
772
8180
126
883
617
6728
Assessment of need for rehabilitation and/or rehabilitation plan
SPAT1220 [2001700321]
SPAT1220 [2001700321]
4.3e-01
—
—
—
—
1.9e+00
1.2e+00
cases:0.68%
controls:0.44%
—
—
—
—
—
—
—
—
cases:1.18%
controls:0.17%
cases:1.35%
controls:0.39%
6
39
881
8818
—
—
—
—
10
15
841
8649
10
30
733
7581
Clinic/Center
261Q00000X [38004207]
261Q00000X [38004207]
4.3e-02
—
—
—
-1.0e+50
1.9e+00
6.1e-01
cases:0.79%
controls:0.76%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.94%
controls:0.14%
cases:0.67%
controls:0.37%
7
67
880
8790
—
—
—
0
7
880
8859
8
12
843
8652
5
28
738
7583
other preparations, combinations; ointment
C05AX03 [21601631]
C05AX03 [21601631]
5.5e-01
9.0e-01
-1.0e+50
—
—
1.0e+00
1.0e-01
cases:4.51%
controls:2.64%
cases:2.14%
controls:0.88%
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.88%
controls:0.69%
cases:2.69%
controls:2.43%
40
234
847
8623
19
78
870
8805
0
8
889
8875
—
—
16
60
835
8604
20
185
723
7426
ferrous glycine sulfate; oral
B03AA01 [21601080]
B03AA01 [21601080]
3.1e-01
8.2e-01
—
—
2.1e+00
1.9e+00
7.6e-01
cases:0.68%
controls:0.50%
cases:0.56%
controls:0.25%
—
—
—
—
cases:0.57%
controls:0.07%
cases:1.76%
controls:0.27%
cases:1.75%
controls:0.83%
6
44
881
8813
5
22
884
8861
—
—
5
6
875
8860
15
23
836
8641
13
63
730
7548
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
1.1e-01
3.1e-01
3.9e-01
—
1.1e+00
4.5e-01
4.0e-01
cases:19.39%
controls:17.71%
cases:9.11%
controls:6.82%
cases:1.01%
controls:0.69%
—
—
cases:2.27%
controls:0.80%
cases:10.69%
controls:7.11%
cases:26.24%
controls:19.27%
172
1569
715
7288
81
606
808
8277
9
61
880
8822
—
20
71
860
8795
91
616
760
8048
195
1467
548
6144
Remowal of suture of skin
TQW40 [2001310146]
TQW40 [2001310146]
1.0e+00
—
—
1.0e+50
1.0e+50
—
1.9e+00
cases:1.01%
controls:0.36%
—
—
—
—
cases:0.56%
controls:0.00%
cases:1.36%
controls:0.00%
—
—
cases:2.15%
controls:0.33%
9
32
878
8825
—
—
5
0
884
8883
12
0
868
8866
—
16
25
727
7586
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
N03AG01 [21604422]
9.0e-01
6.0e-01
—
—
—
8.6e-01
1.0e+00
cases:2.48%
controls:1.03%
cases:1.57%
controls:0.87%
—
—
—
—
—
—
cases:2.00%
controls:0.85%
cases:2.69%
controls:1.01%
22
91
865
8766
14
77
875
8806
—
—
—
17
74
834
8590
20
77
723
7534
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
5.8e-01
6.6e-01
—
—
—
1.9e+00
7.9e-01
cases:1.47%
controls:0.82%
cases:0.67%
controls:0.35%
—
—
—
—
—
—
cases:1.06%
controls:0.16%
cases:1.75%
controls:0.80%
13
73
874
8784
6
31
883
8852
—
—
—
9
14
842
8650
13
61
730
7550
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
2.9e-01
2.2e-01
6.3e-01
—
8.9e-01
5.4e-01
4.6e-01
cases:11.27%
controls:8.68%
cases:6.75%
controls:5.47%
cases:1.80%
controls:0.97%
—
—
cases:2.95%
controls:1.24%
cases:9.52%
controls:5.78%
cases:18.57%
controls:12.60%
100
769
787
8088
60
486
829
8397
16
86
873
8797
—
26
110
854
8756
81
501
770
8163
138
959
605
6652
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
2.9e-01
2.3e-01
6.2e-01
—
8.8e-01
5.4e-01
4.7e-01
cases:11.27%
controls:8.66%
cases:6.75%
controls:5.46%
cases:1.80%
controls:0.98%
—
—
cases:2.95%
controls:1.25%
cases:9.52%
controls:5.79%
cases:18.57%
controls:12.48%
100
767
787
8090
60
485
829
8398
16
87
873
8796
—
26
111
854
8755
81
502
770
8162
138
950
605
6661
Psychiatric treatment plan, extended/prolonged
ICB02 [2001304099]
ICB02 [2001304099]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.14%
—
—
—
—
—
—
7
11
736
7600
Nutritional therapy
R4190 [2001310243]
R4190 [2001310243]
—
1.1e+00
—
—
—
1.9e+00
1.0e+00
—
—
cases:0.56%
controls:0.19%
—
—
—
—
—
—
cases:0.82%
controls:0.13%
cases:1.08%
controls:0.39%
—
5
17
884
8866
—
—
—
7
11
844
8653
8
30
735
7581
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
47
65
7.57
32.47
2.4
1.4
1.76
1.15
promille
1.33
35
52
171
724
2.67
26.72
3.7
3.3
—
—
—
0
0
369
2236
2.08
24.66
2.9
2.2
299.79
282.61
u/l
0.10
351
2140
180
863
2.35
21.22
2.0
1.9
—
—
—
0
0
318
1925
2.00
20.49
6.2
4.5
88.57
89.36
%
0.23
313
1897
181
914
2.22
18.69
2.0
1.8
—
—
—
0
0
535
3943
1.85
18.12
7.5
7.1
10.73
12.56
umol/l
2.71
518
3764
151
717
2.32
18.02
7.5
9.7
8.86
9.28
mmol/l
0.24
146
691
27
39
7.10
17.89
8.6
2.1
144.17
120.90
umol/l
0.19
18
21
171
864
2.20
17.55
13.3
11.6
5.07
5.15
kpa
0.48
166
836
171
865
2.20
17.50
13.3
11.6
12.30
12.41
kpa
0.09
166
841
169
851
2.21
17.49
13.4
11.7
0.93
0.88
mmol/l
0.06
141
727
163
817
2.21
17.03
5.3
5.2
5.81
5.84
kpa
0.19
158
797
159
789
2.23
17.03
5.4
5.3
1.29
1.71
mmol/l
0.81
145
678
219
1230
2.02
16.97
2.0
2.0
—
—
—
0
0
451
3248
1.76
15.62
10.7
8.4
1.20
1.21
mmol/l
2.65
430
3028
211
1202
1.98
15.56
3.0
1.9
1.53
1.49
%
0.42
187
1067
139
696
2.17
14.44
4.1
4.7
4.74
4.59
kpa
0.36
134
678
220
1311
1.89
14.04
4.1
4.3
0.80
0.82
mmol/l
1.23
209
1257
437
3189
1.70
13.88
5.9
5.7
34.85
36.12
g/l
4.03
422
3002
187
1064
1.95
13.68
7.5
7.5
1.04
1.05
mmol/l
0.22
175
1010
221
1331
1.87
13.59
3.2
3.0
1.07
0.85
e6/l
0.39
116
692
482
3628
1.69
13.50
11.7
8.8
1.20
1.21
mmol/l
1.89
434
3176
209
1249
1.87
13.12
3.3
3.2
3.79
1.92
e6/l
0.99
103
613
98
446
2.34
12.75
2.6
1.7
0.31
0.33
mg/l
0.18
69
230
379
2719
1.67
12.43
4.3
3.6
40.60
34.07
u/l
0.57
357
2578
281
1866
1.73
12.27
3.0
2.5
—
—
—
0
0
351
2482
1.67
12.09
4.3
3.4
32.38
78.99
e6/l
1.00
275
1884
598
4842
1.67
12.02
5.6
4.3
378.88
990.45
e6/l
—
8
73
559
4459
1.65
11.82
9.1
6.2
6.72
6.67
mmol/l
0.23
538
4205
310
2139
1.68
11.63
4.0
3.3
0.71
0.40
e6/l
0.74
231
1554
95
445
2.27
11.55
1.8
1.6
—
—
—
0
0
43
134
3.32
11.49
1.4
1.4
—
—
—
0
0
43
134
3.32
11.49
1.4
1.4
—
—
—
0
0
680
5745
1.70
11.12
9.4
8.4
81.03
80.37
u/l
0.13
658
5473
218
1407
1.72
10.30
4.3
3.8
220.93
619.81
ng/l
2.28
168
1045
178
1088
1.79
10.16
1.7
1.7
1264.94
1159.26
nmol/l
0.43
143
852
130
733
1.90
9.58
2.7
2.7
0.21
0.21
g/l
0.24
120
683
451
3543
1.53
9.20
3.5
2.9
—
—
estimate
—
0
0
107
580
1.96
8.85
2.9
2.4
6.59
8.25
ug/l
0.68
100
524
424
3319
1.51
8.60
16.0
13.5
1.20
1.23
inr
0.51
355
2757
833
7638
1.95
8.25
23.2
15.0
27.03
24.16
mg/l
1.57
727
6250
404
3157
1.50
8.11
2.2
2.0
91.89
96.36
pmol/l
1.18
233
1751
243
1702
1.58
8.08
3.6
2.7
11.76
4.77
e6/l
0.48
219
1555
248
1747
1.57
8.04
2.1
1.9
1.18
1.21
mg/l
0.05
189
1339
537
4456
1.49
7.94
10.9
10.1
4.27
4.09
e9/l
0.98
460
3870
325
2436
1.52
7.93
3.2
3.4
2.34
2.35
mmol/l
0.72
291
2233
147
914
1.72
7.79
3.6
3.2
6.03
8.39
umol/l
1.30
132
811
417
3312
1.47
7.55
2.7
2.6
71.78
74.18
nmol/l
0.95
383
3026
123
735
1.78
7.48
3.0
2.6
29.97
104.59
u/l
0.60
99
630
194
1318
1.60
7.26
2.2
2.9
2.44
2.44
mmol/l
0.12
170
1181
23
65
3.60
7.18
1.9
1.5
—
—
—
0
0
273
2035
1.49
6.62
1.8
1.7
19.41
19.96
nmol/l
0.27
230
1753
24
76
3.22
6.33
2.5
1.8
—
—
—
0
0
333
2615
1.43
6.04
4.5
3.6
7.43
8.35
mmol/l
2.85
285
2262
626
5510
1.42
5.77
5.1
3.5
56.33
48.66
u/l
1.70
590
5251
65
347
1.94
5.65
1.4
1.4
—
—
—
0
0
42
192
2.24
5.49
1.6
1.7
—
—
—
0
0
44
209
2.16
5.25
3.8
3.2
4.21
2.17
index
0.33
19
127
304
2397
1.40
5.23
3.5
2.8
54.51
62.56
u/l
1.58
293
2249
626
5565
1.39
5.05
4.1
4.2
11.76
10.49
mm/h
1.34
591
5221
86
522
1.71
4.96
5.2
5.0
93.99
87.84
ng/l
0.22
74
476
85
516
1.71
4.90
1.9
1.7
—
—
—
0
0
480
4124
1.34
4.63
4.4
3.6
0.04
0.39
estimate
0.44
94
794
478
4105
1.34
4.62
4.4
3.6
40.16
5.32
estimate
0.87
100
853
71
420
1.75
4.50
1.4
1.5
—
—
—
0
0
814
7649
1.55
4.41
27.8
17.7
139.45
139.66
mmol/l
1.83
804
7503
472
4064
1.33
4.40
4.4
3.6
0.00
0.00
estimate
-0.00
99
853
58
326
1.83
4.36
1.7
1.8
1.48
1.49
g/l
0.03
49
296
153
1099
1.47
4.31
3.0
2.8
21.27
23.66
%
1.37
143
1035
644
5814
1.36
4.30
4.8
4.1
14.58
14.72
pmol/l
0.77
604
5351
164
1195
1.45
4.29
3.0
2.7
2.30
2.31
g/l
0.07
152
1113
47
248
1.94
4.28
1.9
2.8
3.30
2.94
g/l
1.21
41
234
13
29
4.53
4.25
4.4
1.5
—
—
—
0
0
252
1983
1.37
4.25
2.6
2.2
2.72
2.78
mg/l
0.15
220
1721
813
7658
1.53
4.12
27.7
17.9
3.99
3.97
mmol/l
0.67
801
7497
85
543
1.62
4.07
3.2
4.2
1.23
1.22
mmol/l
0.76
71
469
48
262
1.88
3.97
1.9
2.7
4.17
4.25
g/l
0.32
42
248
48
262
1.88
3.97
1.9
2.7
3.84
3.55
g/l
1.17
42
248
48
262
1.88
3.97
1.9
2.7
7.84
7.21
g/l
1.54
42
248
41
213
1.97
3.92
1.3
1.1
—
—
—
0
0
41
214
1.96
3.88
1.3
1.1
—
—
—
0
0
170
1278
1.40
3.73
3.0
2.7
12.76
13.63
umol/l
0.60
162
1193
80
517
1.60
3.67
4.2
5.4
1.30
1.52
mmol/l
0.13
53
385
42
227
1.89
3.61
2.3
3.0
0.87
1.28
g/l
0.19
33
206
10
21
4.80
3.56
2.8
2.6
22.94
15.96
umol/l
—
10
21
159
1198
1.40
3.44
2.3
2.1
—
—
—
0
0
81
536
1.56
3.38
2.4
3.2
66.51
66.83
g/l
0.13
73
502
13
39
3.37
3.23
2.0
1.7
—
—
—
0
0
844
8086
1.52
3.15
27.2
18.8
79.27
78.41
umol/l
0.27
839
8003
743
6965
1.35
3.15
5.7
4.9
1.85
1.87
mu/l
0.20
702
6500
37
202
1.87
3.11
2.1
3.0
0.00
0.02
g/l
0.50
32
186
40
225
1.81
3.07
2.0
2.8
10.68
10.95
g/l
0.12
34
210
37
204
1.85
3.03
1.5
1.3
—
—
—
0
0
211
1695
1.32
3.00
1.7
1.6
—
—
—
0
0
71
470
1.55
2.98
2.9
3.8
4.42
4.68
pmol/l
1.39
66
424
764
7209
1.35
2.96
21.3
14.1
87.19
86.01
ml/min/173m2
0.76
707
6608
87
603
1.49
2.95
4.3
5.1
5.03
5.12
kpa
0.40
80
583
64
416
1.58
2.91
1.4
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
230
1.77
2.88
3.2
3.6
0.34
0.33
iu/ml
0.05
25
117
35
194
1.84
2.83
2.2
3.0
0.00
0.00
g/l
-0.00
30
173
165
1293
1.34
2.78
2.5
2.2
—
—
—
0
0
77
528
1.50
2.77
2.3
2.4
11.80
15.29
au/ml
—
5
54
329
2841
1.25
2.58
4.5
3.5
76.92
65.26
ng/l
0.12
245
1918
6
11
5.48
2.54
1.2
1.2
—
—
—
0
0
31
172
1.83
2.53
2.7
1.4
16.59
13.88
e6/l
0.06
22
125
586
5391
1.24
2.51
3.7
3.2
—
—
—
0
0
738
6977
1.29
2.47
6.3
6.0
39.26
38.92
mmol/mol
0.43
697
6615
245
2054
1.26
2.47
3.3
3.5
2143.32
1265.47
ng/l
0.70
213
1738
49
314
1.59
2.40
2.3
2.1
5.22
1.91
ug/l
0.49
42
279
260
2205
1.25
2.36
4.7
3.7
0.00
0.01
estimate
1.15
92
786
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
40
2.77
2.28
1.2
1.1
—
—
—
0
0
82
595
1.42
2.24
1.9
2.1
—
—
—
0
0
216
1804
1.26
2.23
4.3
3.5
1.02
1.02
kg/l
0.26
151
1193
867
8425
1.50
2.20
33.7
22.7
252.40
248.84
e9/l
0.82
851
8274
867
8430
1.49
2.13
33.7
22.6
4.52
4.58
e12/l
2.95
850
8257
36
221
1.65
2.12
1.4
1.4
218.91
287.20
ug/g
1.02
21
134
416
3737
1.21
2.12
3.5
3.1
116.60
126.44
ug/l
0.51
396
3526
30
175
1.74
2.12
2.8
1.4
18.88
1448.75
e6/l
0.79
24
134
10
37
2.72
2.07
1.1
1.1
—
—
—
0
0
32
194
1.67
1.98
1.9
4.2
1.10
2.46
ratio
1.92
16
109
270
2338
1.22
1.98
4.3
4.3
8.10
9.48
mg/mmol
0.30
168
1542
19
98
1.96
1.96
2.2
7.7
8.54
7.11
mmol/l
0.63
14
83
831
8038
1.35
1.95
14.2
11.6
28.95
28.19
u/l
0.60
816
7845
100
771
1.33
1.91
9.8
6.5
—
—
—
0
0
8
28
2.87
1.86
1.8
3.5
10.85
10.60
kpa
—
8
28
8
28
2.87
1.86
1.8
3.5
5.04
4.87
kpa
—
8
28
8
28
2.87
1.86
3.1
4.5
—
—
—
0
0
49
340
1.47
1.74
3.3
3.2
1.02
1.02
ratio
0.45
41
319
133
1084
1.27
1.70
2.3
2.7
89.64
125.31
ug/g
1.40
106
883
51
359
1.45
1.69
2.9
2.4
5656.00
4811.04
u/l
0.05
20
154
76
575
1.35
1.67
2.8
2.7
72.93
71.67
ml/min/173m2
0.08
29
241
51
361
1.44
1.65
2.2
1.6
391.84
291.79
mu/l
1.11
45
334
15
76
1.99
1.65
1.0
1.1
—
—
—
0
0
90
701
1.31
1.63
2.2
2.2
—
—
—
0
0
748
7177
1.22
1.63
5.2
4.7
5.97
5.91
mmol/l
0.60
694
6662
17
91
1.88
1.61
1.2
1.3
—
—
—
0
0
6
20
3.01
1.58
1.2
1.1
—
—
—
0
0
29
184
1.59
1.56
1.6
1.6
—
—
—
0
0
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
33
219
1.53
1.48
1.2
1.7
—
—
—
0
0
9
38
2.38
1.46
4.2
1.9
138.56
107.44
ng/l
—
9
38
41
287
1.45
1.43
1.6
1.7
—
—
—
0
0
6
23
2.62
1.37
1.0
1.2
—
—
—
0
0
14
75
1.88
1.35
1.1
1.0
—
—
—
0
0
16
90
1.79
1.33
1.5
1.3
1.14
1.51
nmol/l
0.94
16
83
161
1379
1.20
1.31
1.3
1.3
16.47
27.89
iu/ml
1.94
46
411
340
3099
1.15
1.30
4.3
3.4
0.01
0.02
estimate
0.42
86
725
779
7548
1.21
1.28
5.6
5.4
2.70
2.72
mmol/l
0.39
736
7104
12
62
1.95
1.28
1.5
1.6
—
—
—
0
0
736
7104
1.18
1.22
4.4
4.1
1.35
1.30
mmol/l
0.86
684
6655
225
2005
1.16
1.16
2.6
2.9
358.25
348.49
umol/l
0.74
199
1815
5
20
2.51
1.15
1.2
1.1
—
—
—
0
0
16
95
1.70
1.14
1.3
1.9
—
—
—
0
0
36
259
1.41
1.13
2.5
2.9
—
—
—
0
0
11
194
0.56
1.10
1.0
1.1
4.68
1.56
u/ml
—
6
114
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
26
178
1.47
1.06
1.9
2.4
138.16
132.11
g/l
0.57
19
144
23
154
1.51
1.04
1.4
1.5
—
—
—
0
0
23
154
1.51
1.04
1.9
1.5
—
—
—
0
0
17
107
1.60
1.00
1.3
1.5
41.98
26.69
ng/l
0.42
17
107
769
7482
1.17
0.99
5.1
4.9
4.52
4.59
mmol/l
1.05
730
7082
13
76
1.72
0.99
1.4
1.7
—
—
—
0
0
13
76
1.72
0.99
1.4
1.7
—
—
—
0
0
13
76
1.72
0.99
1.4
1.7
—
—
—
0
0
14
84
1.68
0.98
1.2
2.0
—
—
—
0
0
7
37
1.90
0.94
1.4
1.1
266.57
79.81
u/l
—
7
31
70
573
1.24
0.93
1.4
1.4
—
—
—
0
0
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
6
29
2.08
0.89
1.7
1.3
6.42
9.01
ug/l
—
6
29
42
326
1.30
0.86
1.3
1.4
313.62
230.77
miu/ml
0.63
18
162
12
191
0.62
0.85
1.8
2.4
53.80
79.84
ug/min
—
5
108
62
507
1.24
0.85
2.3
3.0
321.89
186.73
ng/l
0.84
56
459
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
16
105
1.53
0.82
1.3
1.7
—
—
—
0
0
24
172
1.41
0.81
1.3
1.6
—
—
—
0
0
17
114
1.50
0.80
1.3
1.6
—
—
—
0
0
30
225
1.34
0.79
1.2
1.8
—
—
—
0
0
19
131
1.46
0.79
1.2
1.2
—
—
—
0
0
162
1454
1.14
0.77
1.7
1.7
445.15
16520776.89
pmol/l
0.92
144
1253
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
762
7446
1.14
0.75
4.9
4.8
1.36
1.40
mmol/l
2.07
710
7009
75
876
0.84
0.71
4.7
4.5
30.97
31.11
%
0.04
59
607
325
3051
1.10
0.71
4.9
5.0
2.25
2.14
ug/l
0.16
297
2795
7
41
1.71
0.70
1.4
2.0
—
—
—
0
0
7
41
1.71
0.70
1.4
2.0
—
—
—
0
0
143
1284
1.13
0.69
1.3
1.3
4.59
9.85
u/ml
1.15
56
515
20
144
1.40
0.68
1.3
1.8
—
—
—
0
0
24
179
1.35
0.67
2.7
3.2
1.34
1.54
mmol/l
0.49
24
173
7
43
1.63
0.67
3.0
2.7
661.29
728.14
u/ml
—
7
43
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
89
1017
0.86
0.66
2.1
1.9
3.67
3.59
ratio
0.22
70
805
12
78
1.55
0.65
2.9
3.9
—
—
—
0
0
36
287
1.26
0.64
2.3
2.0
—
—
—
0
0
27
207
1.31
0.64
1.8
1.4
—
—
—
0
0
26
199
1.32
0.63
1.3
1.6
—
—
—
0
0
64
746
0.85
0.61
1.8
1.7
3.70
3.49
mmol/l
0.76
45
541
8
50
1.61
0.61
1.1
1.1
205.08
246.06
iu/ml
—
8
50
57
671
0.84
0.61
4.4
4.8
19.43
21.43
ug/l
0.05
51
555
16
221
0.72
0.60
1.1
1.1
5.96
2.28
u/ml
—
9
136
214
1987
1.10
0.58
1.5
1.3
2.62
1.77
u/ml
0.30
64
568
23
175
1.32
0.58
1.1
1.2
—
1.02
—
0
9
13
89
1.47
0.58
1.6
2.5
32.00
33.04
pg
0.35
13
89
6
35
1.72
0.57
1.2
1.1
22.50
15.86
u/l
—
6
29
33
265
1.25
0.57
2.4
1.8
—
—
—
0
0
8
54
1.49
0.57
1.0
1.2
—
—
—
0
0
12
81
1.49
0.57
1.1
1.1
—
—
—
0
0
18
134
1.35
0.53
1.3
1.1
—
1.96
—
0
6
53
453
1.18
0.52
1.1
1.0
—
—
—
0
0
21
161
1.31
0.52
1.2
1.5
—
—
—
0
0
32
260
1.24
0.51
1.6
1.6
71.06
64.06
ug/l
0.27
24
230
18
135
1.34
0.51
1.3
1.6
—
—
—
0
0
20
153
1.31
0.50
1.2
1.1
—
—
—
0
0
21
162
1.30
0.50
1.1
1.1
330.20
63.80
iu/ml
—
5
40
29
234
1.25
0.50
1.6
1.5
1.28
1.20
ratio
0.13
15
156
29
234
1.25
0.50
1.6
1.5
1.35
1.21
ratio
0.23
15
156
29
234
1.25
0.50
1.6
1.5
0.90
0.93
ratio
0.19
15
156
258
2435
1.08
0.49
4.4
4.1
22.37
21.32
%
0.44
125
1055
40
338
1.19
0.46
1.8
1.9
6.20
6.99
iu/ml
—
9
82
18
139
1.30
0.44
3.4
4.2
5.65
9.51
pmol/l
2.10
18
139
5
31
1.62
0.43
1.8
1.3
—
—
—
0
0
33
276
1.20
0.43
4.2
3.2
3.32
3.55
g/l
0.41
33
267
6
93
0.64
0.42
1.2
1.4
—
0.58
nmol/l
—
0
5
5
32
1.57
0.42
1.2
1.2
—
84.60
%
—
0
5
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
2.5
—
42.67
—
0
15
14
105
1.34
0.41
1.1
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
28
232
1.21
0.40
1.6
1.5
—
—
—
0
0
5
36
1.39
0.38
1.6
1.2
310.80
512.10
u/l
—
5
31
5
37
1.35
0.37
1.4
1.2
—
—
—
0
0
5
37
1.35
0.37
1.4
1.2
—
—
—
0
0
9
70
1.29
0.36
1.2
1.1
—
—
—
0
0
11
81
1.36
0.36
8.5
3.1
13.20
13.08
index
—
5
59
20
162
1.24
0.35
1.5
1.7
—
—
—
0
0
5
79
0.63
0.35
1.6
1.7
—
—
—
0
0
108
1000
1.09
0.34
2.1
2.4
13.98
13.64
nmol/l
0.14
100
922
6
44
1.37
0.34
1.7
1.3
26.38
35.22
nmol/l
—
6
35
6
89
0.67
0.33
1.2
1.4
0.50
0.58
nmol/l
—
6
83
19
231
0.82
0.33
1.5
1.7
—
—
—
0
0
14
175
0.80
0.31
1.3
1.6
60.49
52.57
ug/l
0.41
14
175
7
54
1.30
0.30
1.9
1.5
71.57
79.65
umol/l
—
7
54
188
1792
1.06
0.29
1.6
1.5
2.50
2.39
g/l
0.30
110
1157
8
62
1.29
0.28
1.0
1.8
—
—
—
0
0
8
65
1.23
0.27
1.0
1.2
—
—
—
0
0
8
66
1.21
0.26
1.0
1.2
—
—
—
0
0
9
72
1.25
0.25
1.7
1.2
—
—
—
0
0
9
73
1.24
0.25
1.7
1.2
—
—
—
0
0
9
75
1.20
0.25
1.7
1.2
—
—
—
0
0
9
75
1.20
0.25
1.7
1.2
—
—
—
0
0
193
1854
1.05
0.24
3.0
3.0
0.73
0.75
ug/l
0.17
133
1102
13
158
0.82
0.23
3.8
4.0
40.73
27.01
mg/l
—
8
111
14
115
1.22
0.23
1.2
1.3
—
—
—
0
0
12
97
1.24
0.23
1.3
1.4
8.06
7.50
mmol/l
0.12
12
85
23
200
1.15
0.22
1.4
1.5
149.00
161.51
au/ml
—
5
58
17
144
1.18
0.22
3.4
3.4
9.03
7.57
mmol/l
0.66
17
139
5
41
1.22
0.22
3.8
2.3
29.94
212.25
ug/l
—
5
36
22
191
1.16
0.22
1.2
1.2
—
—
—
0
0
5
42
1.19
0.21
1.4
3.3
0.90
1.29
%
—
5
42
0
11
0.00
0.21
0.0
3.0
—
71.52
—
0
11
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
5
43
1.16
0.21
1.2
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
13.5
—
10.52
—
0
13
15
127
1.18
0.19
1.1
1.3
—
—
—
0
0
6
51
1.18
0.19
1.2
1.1
442.00
230.55
mg/l
—
6
40
18
207
0.87
0.19
2.1
1.7
—
—
—
0
0
25
223
1.12
0.18
1.8
2.4
12.20
11.59
mg/l
0.14
20
210
10
121
0.82
0.18
1.5
2.1
3.90
5.23
mmol/24h
—
10
111
7
62
1.13
0.17
1.0
1.2
83.57
102.11
pmol/l
—
7
62
5
68
0.73
0.17
1.2
1.1
—
79.00
—
0
6
8
69
1.16
0.16
2.9
2.5
—
—
—
0
0
11
92
1.20
0.16
1.0
1.1
—
—
—
0
0
26
287
0.90
0.16
1.3
1.6
0.03
0.03
iu/ml
—
6
43
6
76
0.79
0.15
1.0
1.4
0.17
0.18
nmol/l
—
6
56
6
76
0.79
0.15
1.0
1.1
267.83
278.52
mg/l
—
6
71
50
468
1.07
0.15
1.6
1.6
1170.03
986.93
mu/l
0.69
37
410
37
342
1.09
0.15
1.2
1.5
9.35
7.60
u/l
0.44
26
275
9
80
1.13
0.15
1.7
1.4
—
—
—
0
0
9
80
1.13
0.15
1.7
1.4
—
—
—
0
0
9
81
1.11
0.15
1.7
1.4
—
—
—
0
0
9
81
1.11
0.15
1.7
1.1
—
—
—
0
0
9
83
1.09
0.14
1.6
1.4
—
—
—
0
0
7
86
0.81
0.14
1.1
1.5
—
78.00
—
0
5
25
227
1.10
0.14
1.7
2.2
4.18
4.37
iu/l
—
9
92
29
315
0.92
0.13
3.1
1.8
—
—
—
0
0
12
104
1.16
0.12
1.5
1.7
—
—
—
0
0
322
3170
1.02
0.11
1.9
2.0
1.49
1.40
mmol/l
0.86
263
2740
40
377
1.06
0.11
1.2
1.5
16.97
19.79
iu/l
0.34
26
311
18
163
1.11
0.11
1.2
1.2
—
—
—
0
0
5
44
1.14
0.10
1.8
1.1
—
—
—
0
0
5
45
1.11
0.10
1.2
1.3
—
53.33
—
0
6
15
135
1.11
0.09
1.0
1.1
—
—
—
0
0
6
57
1.05
0.08
1.3
3.5
3949.83
1231.65
mg
—
6
57
14
127
1.10
0.08
2.4
2.2
—
1706.67
—
0
6
9
85
1.06
0.07
1.7
1.2
—
—
—
0
0
9
85
1.06
0.07
1.7
1.4
—
—
—
0
0
9
85
1.06
0.07
1.7
1.4
—
—
—
0
0
8
92
0.87
0.06
1.1
1.4
—
—
—
0
0
12
109
1.10
0.06
1.8
3.1
0.80
0.84
nmol/l
—
7
89
235
2324
1.02
0.05
4.0
3.0
0.00
0.05
estimate
0.75
84
673
10
90
1.11
0.05
1.4
1.4
180.20
179.52
pmol/l
—
10
90
33
344
0.96
0.05
1.2
1.1
1.50
1.49
g/l
0.05
33
344
100
981
1.02
0.05
1.5
1.5
—
—
—
0
0
24
230
1.04
0.03
1.3
1.4
228.79
244.64
u/ml
0.11
14
129
20
209
0.96
0.03
1.6
1.4
—
—
—
0
0
12
112
1.07
0.03
1.0
1.0
—
—
—
0
0
35
358
0.98
0.01
1.2
1.2
0.91
0.90
g/l
0.07
35
358
13
137
0.95
0.01
1.1
1.3
1.57
3.65
u/ml
—
7
65
56
552
1.02
0.01
1.3
1.3
155.96
148.38
u/ml
0.04
22
218
14
136
1.03
0.00
1.1
1.1
1.63
1.49
g/l
0.86
14
125
16
164
0.98
0.00
1.1
1.1
16.34
14.50
au/ml
—
5
48
20
196
1.02
0.00
2.7
1.6
40522.12
10507.30
e6/l
0.90
15
142
23
226
1.02
0.00
1.2
1.2
—
3.35
—
0
20
24
238
1.01
0.00
1.2
1.2
—
1.81
—
0
8
27
267
1.01
0.00
1.3
1.3
—
—
—
0
0
31
307
1.01
0.00
1.5
1.5
—
—
—
0
0
29
285
1.02
0.00
1.8
1.7
30.04
12.96
u/ml
—
8
70
22
215
1.02
0.00
1.3
1.3
—
—
—
0
0
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
5
49
1.02
0.00
1.4
1.6
—
—
—
0
0
6
59
1.02
-0.00
1.2
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
10.40
—
0
5
20
200
1.00
-0.00
1.5
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
3.41
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
1.35
—
0
8
0
9
0.00
-0.00
0.0
1.0
—
12.99
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
65.67
—
0
6
5
52
0.96
-0.00
1.8
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
5
59
0.85
-0.00
13.8
3.2
1.00
0.97
index
—
5
59
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
5.98
—
0
5
0
6
0.00
-0.00
0.0
5.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
10.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
6.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.1
—
0.38
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
-0.00
2.8
2.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_BURNS_CORROSIO_MULTIPLE_UNSPE_BODY_REGIONS – Burns and corrosions of multiple and unspecified body regions
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).